| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.808 | 0.004 | 0.936 | Aldehyde oxidase inhibitor | 0.549 0.026 DBMET00255 0.403 0.046 DBMET01957 0.665 0.011 DBMET01958 0.625 0.016 DBMET01959 0.936 0.003 DBMET00254 0.713 0.007 DBMET00314 0.529 0.029 DBMET01961 0.303 0.065 DBMET00680 | DBMET00254 | |
| 0.6 | 0.006 | 0.645 | Psychostimulant | 0.645 0.005 DBMET00255 0.306 0.041 DBMET01957 0.396 0.023 DBMET01958 0.533 0.009 DBMET01959 0.569 0.007 DBMET00254 0.609 0.005 DBMET00314 0.452 0.016 DBMET01961 0.58 0.007 DBMET00680 0.622 0.005 DBMET01956 | DBMET00255 | |
| 0.626 | 0.033 | 0.753 | Caspase 9 stimulant | 0.51 0.056 DBMET00255 0.378 0.125 DBMET01957 0.612 0.035 DBMET01958 0.566 0.041 DBMET01959 0.753 0.017 DBMET00254 0.644 0.03 DBMET00314 0.499 0.06 DBMET01961 0.728 0.02 DBMET00680 0.601 0.036 DBMET01956 | DBMET00254 | |
| 0.58 | 0.015 | 0.723 | Spasmolytic | 0.504 0.022 DBMET00255 0.227 0.102 DBMET01957 0.23 0.1 DBMET01958 0.387 0.043 DBMET01959 0.622 0.011 DBMET00254 0.561 0.017 DBMET00314 0.5 0.023 DBMET01961 0.723 0.005 DBMET00680 0.667 0.008 DBMET01956 | DBMET00680 | |
| 0.558 | 0.003 | 0.558 | 5 Hydroxytryptamine 5A antagonist | 0.449 0.003 DBMET00255 0.098 0.016 DBMET01957 0.179 0.005 DBMET01958 0.291 0.004 DBMET01959 0.446 0.003 DBMET00254 0.306 0.004 DBMET00314 0.066 0.036 DBMET01961 | ||
| 0.555 | 0.005 | 0.555 | Sigma receptor agonist | 0.503 0.009 DBMET00255 0.414 0.02 DBMET01957 0.198 0.062 DBMET01958 0.454 0.014 DBMET01959 0.524 0.008 DBMET00254 0.479 0.012 DBMET00314 0.249 0.049 DBMET01961 0.168 0.074 DBMET00680 0.141 0.092 DBMET01956 | ||
| 0.529 | 0.004 | 0.543 | Alpha 2b adrenoreceptor antagonist | 0.543 0.004 DBMET00255 0.244 0.015 DBMET01957 0.295 0.009 DBMET01958 0.337 0.007 DBMET01959 0.475 0.004 DBMET00254 0.488 0.004 DBMET00314 0.121 0.057 DBMET01961 | DBMET00255 | |
| 0.52 | 0.003 | 0.52 | 5 Hydroxytryptamine 5 antagonist | 0.409 0.003 DBMET00255 0.084 0.019 DBMET01957 0.172 0.006 DBMET01958 0.265 0.004 DBMET01959 0.375 0.003 DBMET00254 0.281 0.004 DBMET00314 0.056 0.043 DBMET01961 | ||
| 0.517 | 0.004 | 0.517 | 5 Hydroxytryptamine 1F antagonist | 0.267 0.007 DBMET00255 0.071 0.049 DBMET01957 0.253 0.007 DBMET01958 0.15 0.016 DBMET01959 0.272 0.006 DBMET00254 0.138 0.019 DBMET00314 | ||
| 0.516 | 0.005 | 0.516 | 5 Hydroxytryptamine 2B antagonist | 0.428 0.007 DBMET00255 0.16 0.037 DBMET01957 0.238 0.02 DBMET01958 0.347 0.011 DBMET01959 0.402 0.008 DBMET00254 0.322 0.013 DBMET00314 0.121 0.059 DBMET01961 | ||
| 0.49 | 0.007 | 0.676 | Cyclic AMP phosphodiesterase inhibitor | 0.32 0.035 DBMET00255 0.218 0.081 DBMET01957 0.41 0.015 DBMET01958 0.353 0.025 DBMET01959 0.515 0.006 DBMET00254 0.344 0.027 DBMET00314 0.253 0.062 DBMET01961 0.676 0.004 DBMET00680 0.498 0.007 DBMET01956 | DBMET00680 | |
| 0.483 | 0.008 | 0.483 | 5 Hydroxytryptamine antagonist | 0.44 0.009 DBMET00255 0.104 0.075 DBMET01957 0.187 0.037 DBMET01958 0.282 0.021 DBMET01959 0.294 0.019 DBMET00254 0.262 0.023 DBMET00314 0.102 0.077 DBMET01961 | ||
| 0.499 | 0.026 | 0.675 | GABA C receptor rho-3 antagonist | 0.508 0.024 DBMET00255 0.398 0.062 DBMET01957 0.675 0.004 DBMET01958 0.534 0.018 DBMET01959 0.499 0.026 DBMET00254 0.507 0.024 DBMET00314 0.36 0.08 DBMET01961 | DBMET01958 | |
| 0.476 | 0.007 | 0.476 | 5 Hydroxytryptamine 2 antagonist | 0.46 0.007 DBMET00255 0.133 0.052 DBMET01957 0.203 0.03 DBMET01958 0.288 0.017 DBMET01959 0.342 0.013 DBMET00254 0.326 0.014 DBMET00314 0.093 0.077 DBMET01961 | ||
| 0.473 | 0.005 | 0.473 | 5 Hydroxytryptamine 7 antagonist | 0.285 0.006 DBMET00255 0.094 0.026 DBMET01957 0.098 0.026 DBMET01958 0.291 0.006 DBMET01959 0.247 0.008 DBMET00254 0.174 0.015 DBMET00314 0.079 0.032 DBMET01961 | ||
| 0.47 | 0.005 | 0.47 | Nav1.2 sodium channel blocker | 0.452 0.005 DBMET00255 0.133 0.069 DBMET01957 0.175 0.045 DBMET01958 0.409 0.007 DBMET01959 0.365 0.009 DBMET00254 0.354 0.01 DBMET00314 0.19 0.038 DBMET01961 | ||
| 0.474 | 0.01 | 0.499 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.379 0.026 DBMET00255 0.27 0.088 DBMET01957 0.499 0.007 DBMET01958 0.463 0.011 DBMET01959 0.41 0.019 DBMET00254 0.335 0.043 DBMET00314 0.345 0.038 DBMET01961 | DBMET01958 | |
| 0.463 | 0.005 | 0.463 | 5 Hydroxytryptamine 2C antagonist | 0.439 0.005 DBMET00255 0.124 0.035 DBMET01957 0.18 0.02 DBMET01958 0.301 0.009 DBMET01959 0.314 0.008 DBMET00254 0.293 0.009 DBMET00314 0.089 0.053 DBMET01961 | ||
| 0.485 | 0.03 | 0.796 | 5 Hydroxytryptamine release stimulant | 0.681 0.008 DBMET00255 0.292 0.072 DBMET01957 0.796 0.004 DBMET01958 0.676 0.009 DBMET01959 0.519 0.024 DBMET00254 0.707 0.007 DBMET00314 0.554 0.019 DBMET01961 0.313 0.066 DBMET00680 0.547 0.02 DBMET01956 | DBMET01958 | |
| 0.448 | 0.004 | 0.448 | Histamine H1 receptor antagonist | 0.338 0.005 DBMET00255 0.147 0.025 DBMET01957 0.089 0.049 DBMET01958 0.236 0.011 DBMET01959 0.278 0.008 DBMET00254 0.199 0.014 DBMET00314 0.191 0.016 DBMET01961 0.088 0.05 DBMET00680 | ||
| 0.43 | 0.004 | 0.432 | Nav1.3 sodium channel blocker | 0.432 0.004 DBMET00255 0.118 0.076 DBMET01957 0.164 0.039 DBMET01958 0.284 0.01 DBMET01959 0.309 0.008 DBMET00254 0.31 0.008 DBMET00314 0.124 0.069 DBMET01961 | DBMET00255 | |
| 0.44 | 0.017 | 0.478 | Anticonvulsant | 0.383 0.024 DBMET00255 0.286 0.044 DBMET01958 0.424 0.019 DBMET01959 0.241 0.061 DBMET00254 0.206 0.079 DBMET00314 0.478 0.014 DBMET01961 | DBMET01961 | |
| 0.427 | 0.005 | 0.427 | Butyrylcholinesterase inhibitor | 0.287 0.011 DBMET00255 0.148 0.035 DBMET01957 0.173 0.027 DBMET01958 0.233 0.017 DBMET01959 0.338 0.008 DBMET00254 0.236 0.017 DBMET00314 0.095 0.066 DBMET01961 | ||
| 0.42 | 0.002 | 0.42 | Histamine N-methyltransferase inhibitor | 0.258 0.004 DBMET00255 0.175 0.008 DBMET01957 0.181 0.007 DBMET01958 0.329 0.003 DBMET01959 0.392 0.003 DBMET00254 0.236 0.004 DBMET00314 0.19 0.006 DBMET01961 0.119 0.03 DBMET00680 | ||
| 0.409 | 0.005 | 0.409 | Antihistaminic | 0.349 0.008 DBMET00255 0.087 0.068 DBMET01957 0.082 0.074 DBMET01958 0.196 0.021 DBMET01959 0.195 0.021 DBMET00254 0.163 0.028 DBMET00314 0.112 0.047 DBMET01961 | ||
| 0.445 | 0.042 | 0.472 | Vasodilator, peripheral | 0.348 0.075 DBMET00255 0.472 0.034 DBMET01958 0.221 0.152 DBMET01959 0.446 0.042 DBMET00254 0.349 0.074 DBMET00314 0.255 0.123 DBMET01961 0.423 0.048 DBMET00680 0.326 0.084 DBMET01956 | DBMET01958 | |
| 0.405 | 0.004 | 0.405 | Nav1.6 sodium channel blocker | 0.333 0.005 DBMET00255 0.147 0.057 DBMET01957 0.221 0.014 DBMET01958 0.306 0.005 DBMET01959 0.308 0.005 DBMET00254 0.254 0.009 DBMET00314 0.158 0.046 DBMET01961 | ||
| 0.427 | 0.028 | 0.649 | Vasodilator, coronary | 0.39 0.038 DBMET00255 0.234 0.15 DBMET01957 0.281 0.104 DBMET01958 0.335 0.063 DBMET01959 0.428 0.028 DBMET00254 0.391 0.038 DBMET00314 0.342 0.059 DBMET01961 0.649 0.005 DBMET00680 0.602 0.008 DBMET01956 | DBMET00680 | |
| 0.404 | 0.005 | 0.404 | Histamine antagonist | 0.345 0.008 DBMET00255 0.077 0.067 DBMET01957 0.188 0.021 DBMET01959 0.179 0.023 DBMET00254 0.148 0.03 DBMET00314 0.092 0.053 DBMET01961 | ||
| 0.423 | 0.025 | 0.423 | Cardiotonic | 0.311 0.052 DBMET00255 0.267 0.072 DBMET01959 0.325 0.047 DBMET00254 0.248 0.084 DBMET00314 0.35 0.039 DBMET01961 0.225 0.099 DBMET00680 0.177 0.143 DBMET01956 | ||
| 0.402 | 0.007 | 0.402 | 5 Hydroxytryptamine 2A antagonist | 0.367 0.008 DBMET00255 0.1 0.047 DBMET01957 0.154 0.027 DBMET01958 0.222 0.017 DBMET01959 0.265 0.014 DBMET00254 0.235 0.016 DBMET00314 | ||
| 0.396 | 0.007 | 0.396 | Anesthetic local | 0.324 0.01 DBMET00255 0.122 0.065 DBMET01957 0.104 0.079 DBMET01958 0.221 0.027 DBMET01959 0.32 0.011 DBMET00254 0.265 0.017 DBMET00314 0.125 0.063 DBMET01961 | ||
| 0.398 | 0.01 | 0.398 | Cholinergic | 0.294 0.019 DBMET00255 0.154 0.073 DBMET01957 0.197 0.048 DBMET01958 0.182 0.055 DBMET01959 0.307 0.018 DBMET00254 0.243 0.03 DBMET00314 0.153 0.074 DBMET01961 | ||
| 0.387 | 0.004 | 0.395 | Alpha 2c adrenoreceptor antagonist | 0.395 0.004 DBMET00255 0.176 0.023 DBMET01957 0.226 0.013 DBMET01958 0.245 0.011 DBMET01959 0.357 0.005 DBMET00254 0.364 0.005 DBMET00314 0.103 0.063 DBMET01961 0.086 0.08 DBMET00680 0.088 0.077 DBMET01956 | DBMET00255 | |
| 0.383 | 0.005 | 0.388 | Alpha 2a adrenoreceptor antagonist | 0.388 0.005 DBMET00255 0.126 0.028 DBMET01957 0.22 0.012 DBMET01958 0.246 0.009 DBMET01959 0.38 0.005 DBMET00254 0.384 0.005 DBMET00314 0.068 0.06 DBMET01961 | DBMET00255 | |
| 0.383 | 0.01 | 0.39 | Alpha adrenoreceptor antagonist | 0.39 0.01 DBMET00255 0.104 0.054 DBMET01957 0.17 0.033 DBMET01958 0.223 0.024 DBMET01959 0.34 0.013 DBMET00254 0.346 0.012 DBMET00314 0.096 0.059 DBMET01961 | DBMET00255 | |
| 0.372 | 0.004 | 0.372 | 5 Hydroxytryptamine 1D antagonist | 0.291 0.004 DBMET00255 0.071 0.037 DBMET01957 0.155 0.011 DBMET01958 0.193 0.007 DBMET01959 0.234 0.005 DBMET00254 0.177 0.008 DBMET00314 | ||
| 0.437 | 0.07 | 0.603 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.52 0.026 DBMET00255 0.358 0.142 DBMET01957 0.603 0.007 DBMET01958 0.441 0.068 DBMET01959 0.29 0.226 DBMET00254 0.388 0.112 DBMET00314 0.305 0.206 DBMET01961 | DBMET01958 | |
| 0.37 | 0.005 | 0.37 | Nav1.1 sodium channel blocker | 0.339 0.006 DBMET00255 0.164 0.028 DBMET01957 0.124 0.046 DBMET01958 0.309 0.008 DBMET01959 0.321 0.007 DBMET00254 0.298 0.008 DBMET00314 0.183 0.023 DBMET01961 0.092 0.077 DBMET00680 0.088 0.083 DBMET01956 | ||
| 0.426 | 0.062 | 0.589 | Histamine release inhibitor | 0.322 0.113 DBMET00255 0.46 0.045 DBMET01958 0.403 0.074 DBMET01959 0.486 0.034 DBMET00254 0.417 0.067 DBMET00314 0.379 0.086 DBMET01961 0.589 0.011 DBMET00680 0.514 0.024 DBMET01956 | DBMET00680 | |
| 0.361 | 0.003 | 0.361 | Sphingomyelinase inhibitor | 0.315 0.003 DBMET00255 0.17 0.017 DBMET01957 0.138 0.03 DBMET01958 0.238 0.005 DBMET01959 0.287 0.004 DBMET00254 0.262 0.004 DBMET00314 0.183 0.013 DBMET01961 0.27 0.004 DBMET00680 0.248 0.004 DBMET01956 | ||
| 0.363 | 0.008 | 0.363 | Acetylcholinesterase inhibitor | 0.264 0.018 DBMET00255 0.141 0.061 DBMET01957 0.177 0.041 DBMET01958 0.177 0.041 DBMET01959 0.311 0.012 DBMET00254 0.244 0.022 DBMET00314 0.132 0.068 DBMET01961 0.126 0.073 DBMET00680 | ||
| 0.362 | 0.008 | 0.362 | Acetylcholine M1 receptor antagonist | 0.312 0.012 DBMET00255 0.171 0.057 DBMET01957 0.188 0.048 DBMET01958 0.312 0.012 DBMET01959 0.343 0.009 DBMET00254 0.298 0.015 DBMET00314 0.231 0.031 DBMET01961 0.119 0.11 DBMET00680 | ||
| 0.354 | 0.009 | 0.798 | DNA intercalator | 0.201 0.025 DBMET00255 0.798 0.003 DBMET01957 0.112 0.063 DBMET01958 0.196 0.027 DBMET01959 0.299 0.012 DBMET00254 0.193 0.028 DBMET00314 0.147 0.044 DBMET01961 0.283 0.013 DBMET00680 0.213 0.022 DBMET01956 | DBMET01957 | |
| 0.344 | 0.008 | 0.344 | 5 Hydroxytryptamine 1 antagonist | 0.286 0.011 DBMET00255 0.119 0.03 DBMET01958 0.156 0.022 DBMET01959 0.233 0.014 DBMET00254 0.187 0.018 DBMET00314 | ||
| 0.336 | 0.004 | 0.359 | Protein kinase C gamma inhibitor | 0.29 0.005 DBMET00255 0.149 0.032 DBMET01957 0.233 0.009 DBMET01958 0.31 0.004 DBMET01959 0.359 0.004 DBMET00254 0.316 0.004 DBMET00314 0.278 0.005 DBMET01961 0.178 0.019 DBMET00680 0.148 0.033 DBMET01956 | DBMET00254 | |
| 0.336 | 0.006 | 0.339 | Alpha 2 adrenoreceptor antagonist | 0.339 0.006 DBMET00255 0.104 0.045 DBMET01957 0.213 0.016 DBMET01958 0.214 0.016 DBMET01959 0.307 0.008 DBMET00254 0.31 0.008 DBMET00314 | DBMET00255 | |
| 0.341 | 0.012 | 0.371 | 5 Hydroxytryptamine 1E antagonist | 0.358 0.009 DBMET00255 0.255 0.07 DBMET01957 0.371 0.007 DBMET01958 0.31 0.024 DBMET01959 0.339 0.012 DBMET00254 0.356 0.009 DBMET00314 0.18 0.154 DBMET01961 | DBMET01958 | |
| 0.328 | 0.004 | 0.328 | 5 Hydroxytryptamine 1B antagonist | 0.279 0.005 DBMET00255 0.061 0.05 DBMET01957 0.153 0.012 DBMET01958 0.17 0.011 DBMET01959 0.206 0.008 DBMET00254 0.167 0.011 DBMET00314 | ||
| 0.338 | 0.019 | 0.338 | Ca(v)3.3 blocker | 0.295 0.047 DBMET00255 0.263 0.082 DBMET01959 0.258 0.089 DBMET00254 0.217 0.158 DBMET00314 | ||
| 0.327 | 0.012 | 0.327 | Antiadrenergic | 0.317 0.012 DBMET00255 0.091 0.062 DBMET01957 0.17 0.031 DBMET01958 0.216 0.021 DBMET01959 0.24 0.018 DBMET00254 0.239 0.018 DBMET00314 0.114 0.048 DBMET01961 | ||
| 0.323 | 0.01 | 0.329 | Alpha 1 adrenoreceptor antagonist | 0.329 0.009 DBMET00255 0.092 0.046 DBMET01957 0.14 0.031 DBMET01958 0.181 0.024 DBMET01959 0.271 0.013 DBMET00254 0.276 0.013 DBMET00314 0.071 0.058 DBMET01961 | DBMET00255 | |
| 0.351 | 0.04 | 0.59 | DNA damaging | 0.321 0.05 DBMET00255 0.59 0.009 DBMET01957 0.275 0.068 DBMET01958 0.378 0.033 DBMET01959 0.38 0.033 DBMET00254 0.352 0.04 DBMET00314 0.279 0.066 DBMET01961 0.411 0.026 DBMET00680 0.382 0.032 DBMET01956 | DBMET01957 | |
| 0.314 | 0.004 | 0.314 | Acetylcholine M4 receptor antagonist | 0.188 0.007 DBMET00255 0.109 0.022 DBMET01957 0.109 0.022 DBMET01958 0.148 0.01 DBMET01959 0.152 0.01 DBMET00254 0.105 0.024 DBMET00314 0.068 0.06 DBMET01961 | ||
| 0.319 | 0.012 | 0.319 | Adrenaline antagonist | 0.306 0.013 DBMET00255 0.087 0.062 DBMET01957 0.166 0.031 DBMET01958 0.209 0.022 DBMET01959 0.233 0.019 DBMET00254 0.231 0.019 DBMET00314 0.108 0.049 DBMET01961 | ||
| 0.322 | 0.019 | 0.326 | MAP-kinase-activated kinase 5 inhibitor | 0.316 0.022 DBMET00255 0.164 0.159 DBMET01957 0.289 0.036 DBMET01958 0.326 0.018 DBMET01959 0.305 0.028 DBMET00254 0.3 0.03 DBMET00314 0.262 0.052 DBMET01961 | DBMET01959 | |
| 0.337 | 0.04 | 0.406 | HERG channel blocker | 0.178 0.104 DBMET00255 0.406 0.027 DBMET01957 | DBMET01957 | |
| 0.299 | 0.009 | 0.316 | Alpha 1a adrenoreceptor antagonist | 0.316 0.008 DBMET00255 0.087 0.042 DBMET01957 0.129 0.027 DBMET01958 0.161 0.022 DBMET01959 0.236 0.013 DBMET00254 0.253 0.012 DBMET00314 | DBMET00255 | |
| 0.293 | 0.01 | 0.293 | Acetylcholine muscarinic antagonist | 0.236 0.017 DBMET00255 0.118 0.069 DBMET01957 0.113 0.075 DBMET01958 0.204 0.023 DBMET01959 0.27 0.012 DBMET00254 0.217 0.02 DBMET00314 0.184 0.029 DBMET01961 | ||
| 0.291 | 0.008 | 0.341 | Alpha 1b adrenoreceptor antagonist | 0.341 0.006 DBMET00255 0.101 0.035 DBMET01957 0.158 0.02 DBMET01958 0.189 0.016 DBMET01959 0.25 0.01 DBMET00254 0.285 0.008 DBMET00314 | DBMET00255 | |
| 0.292 | 0.014 | 0.311 | Toll-Like receptor 9 antagonist | 0.311 0.011 DBMET00255 0.201 0.035 DBMET01958 0.137 0.071 DBMET01959 0.247 0.021 DBMET00254 0.269 0.017 DBMET00314 | DBMET00255 | |
| 0.303 | 0.032 | 0.317 | Anesthetic general | 0.219 0.065 DBMET00255 0.295 0.034 DBMET01958 0.239 0.055 DBMET01959 0.317 0.029 DBMET00254 0.23 0.059 DBMET00314 0.188 0.081 DBMET01961 0.295 0.034 DBMET00680 0.212 0.068 DBMET01956 | DBMET00254 | |
| 0.273 | 0.004 | 0.318 | Prolactin inhibitor | 0.185 0.012 DBMET00255 0.141 0.026 DBMET01957 0.235 0.005 DBMET01958 0.195 0.009 DBMET01959 0.318 0.003 DBMET00254 0.224 0.005 DBMET00314 0.122 0.037 DBMET01961 | DBMET00254 | |
| 0.275 | 0.008 | 0.311 | 5 Hydroxytryptamine 3E antagonist | 0.279 0.008 DBMET00255 0.198 0.065 DBMET01957 0.311 0.004 DBMET01958 0.261 0.012 DBMET01959 0.223 0.033 DBMET00254 0.227 0.03 DBMET00314 0.175 0.121 DBMET01961 | DBMET01958 | |
| 0.273 | 0.006 | 0.3 | Alpha 1d adrenoreceptor antagonist | 0.3 0.005 DBMET00255 0.082 0.03 DBMET01957 0.125 0.018 DBMET01958 0.162 0.013 DBMET01959 0.211 0.009 DBMET00254 0.231 0.008 DBMET00314 | DBMET00255 | |
| 0.274 | 0.01 | 0.274 | 5 Hydroxytryptamine 1A antagonist | 0.216 0.013 DBMET00255 0.057 0.056 DBMET01957 0.109 0.029 DBMET01958 0.137 0.022 DBMET01959 0.2 0.015 DBMET00254 0.153 0.02 DBMET00314 | ||
| 0.27 | 0.006 | 0.358 | Protein kinase C zeta inhibitor | 0.188 0.013 DBMET00255 0.089 0.068 DBMET01957 0.179 0.014 DBMET01958 0.284 0.005 DBMET01959 0.358 0.004 DBMET00254 0.277 0.006 DBMET00314 0.222 0.009 DBMET01961 0.088 0.069 DBMET00680 | DBMET00254 | |
| 0.296 | 0.035 | 0.54 | Tyrosine 3 hydroxylase inhibitor | 0.303 0.032 DBMET00255 0.267 0.054 DBMET01957 0.54 0.004 DBMET01958 0.372 0.012 DBMET01959 0.343 0.018 DBMET00254 0.35 0.016 DBMET00314 0.29 0.038 DBMET01961 | DBMET01958 | |
| 0.265 | 0.005 | 0.385 | Photosensitizer | 0.157 0.027 DBMET00255 0.125 0.051 DBMET01957 0.225 0.009 DBMET01958 0.199 0.013 DBMET01959 0.259 0.005 DBMET00254 0.154 0.029 DBMET00314 0.162 0.025 DBMET01961 0.385 0.003 DBMET00680 0.227 0.008 DBMET01956 | DBMET00680 | |
| 0.275 | 0.017 | 0.275 | Cholinergic antagonist | 0.238 0.023 DBMET00255 0.111 0.082 DBMET01958 0.196 0.033 DBMET01959 0.247 0.021 DBMET00254 0.212 0.029 DBMET00314 0.189 0.035 DBMET01961 | ||
| 0.265 | 0.008 | 0.421 | Telomerase inhibitor | 0.158 0.019 DBMET00255 0.421 0.004 DBMET01957 0.091 0.038 DBMET01958 0.177 0.017 DBMET01959 0.196 0.014 DBMET00254 0.116 0.027 DBMET00314 0.125 0.025 DBMET01961 0.07 0.052 DBMET00680 | DBMET01957 | |
| 0.264 | 0.008 | 0.428 | 5 Hydroxytryptamine uptake inhibitor | 0.385 0.005 DBMET00255 0.428 0.005 DBMET01957 0.06 0.046 DBMET01958 0.097 0.027 DBMET01959 0.121 0.02 DBMET00254 0.219 0.01 DBMET00314 0.055 0.051 DBMET01961 | DBMET01957 | |
| 0.263 | 0.007 | 0.421 | Dopamine D1 antagonist | 0.201 0.01 DBMET00255 0.09 0.028 DBMET01957 0.129 0.018 DBMET01958 0.132 0.018 DBMET01959 0.421 0.004 DBMET00254 0.355 0.005 DBMET00314 | DBMET00254 | |
| 0.291 | 0.04 | 0.321 | Gastrin inhibitor | 0.321 0.021 DBMET00255 0.23 0.105 DBMET01957 0.311 0.026 DBMET01958 0.276 0.052 DBMET01959 0.226 0.111 DBMET00254 0.263 0.064 DBMET00314 0.213 0.13 DBMET01961 0.182 0.176 DBMET00680 0.226 0.111 DBMET01956 | DBMET00255 | |
| 0.3 | 0.05 | 0.342 | Potassium channel (Voltage-sensitive) blocker | 0.178 0.113 DBMET00255 0.342 0.038 DBMET01957 | DBMET01957 | |
| 0.26 | 0.015 | 0.26 | Calcium channel blocker | 0.196 0.032 DBMET00255 0.129 0.078 DBMET01957 0.145 0.063 DBMET01959 0.167 0.046 DBMET00254 0.121 0.087 DBMET00314 | ||
| 0.263 | 0.018 | 0.263 | Acetylcholine antagonist | 0.227 0.024 DBMET00255 0.108 0.082 DBMET01958 0.189 0.033 DBMET01959 0.238 0.023 DBMET00254 0.202 0.03 DBMET00314 0.151 0.049 DBMET01961 | ||
| 0.256 | 0.014 | 0.256 | Dopamine antagonist | 0.216 0.017 DBMET00255 0.066 0.057 DBMET01957 0.116 0.033 DBMET01958 0.132 0.029 DBMET01959 0.256 0.014 DBMET00254 0.216 0.017 DBMET00314 | ||
| 0.251 | 0.009 | 0.251 | Dopamine D4 antagonist | 0.168 0.015 DBMET00255 0.07 0.037 DBMET01957 0.137 0.019 DBMET01958 0.114 0.023 DBMET01959 0.203 0.012 DBMET00254 0.128 0.02 DBMET00314 | ||
| 0.285 | 0.048 | 0.405 | Amyloid beta aggregation inhibitor | 0.205 0.075 DBMET00255 0.143 0.114 DBMET01958 0.242 0.06 DBMET01959 0.405 0.024 DBMET00254 0.346 0.035 DBMET00314 0.215 0.07 DBMET01961 0.263 0.054 DBMET00680 0.222 0.067 DBMET01956 | DBMET00254 | |
| 0.243 | 0.008 | 0.328 | CXC chemokine 4 receptor antagonist | 0.226 0.009 DBMET00255 0.083 0.03 DBMET01957 0.179 0.012 DBMET01958 0.328 0.004 DBMET01959 0.167 0.013 DBMET00254 0.157 0.014 DBMET00314 0.16 0.014 DBMET01961 | DBMET01959 | |
| 0.262 | 0.028 | 0.382 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.299 0.019 DBMET00255 0.201 0.045 DBMET01958 0.382 0.008 DBMET01959 0.159 0.06 DBMET00254 0.214 0.042 DBMET00314 0.209 0.043 DBMET01961 | DBMET01959 | |
| 0.294 | 0.062 | 0.324 | Insulysin inhibitor | 0.311 0.052 DBMET00255 0.321 0.046 DBMET01958 0.324 0.045 DBMET01959 0.302 0.057 DBMET00254 0.318 0.048 DBMET00314 0.233 0.113 DBMET01961 | DBMET01959 | |
| 0.269 | 0.039 | 0.282 | Neuropeptide Y2 antagonist | 0.243 0.063 DBMET00255 0.26 0.047 DBMET01958 0.282 0.029 DBMET01959 0.262 0.045 DBMET00254 0.233 0.074 DBMET00314 0.197 0.124 DBMET01961 | DBMET01959 | |
| 0.229 | 0.005 | 0.229 | Acetylcholine M2 receptor antagonist | 0.163 0.01 DBMET00255 0.063 0.042 DBMET01957 0.137 0.013 DBMET01959 0.179 0.008 DBMET00254 0.133 0.014 DBMET00314 0.064 0.042 DBMET01961 | ||
| 0.307 | 0.085 | 0.468 | Calcium channel activator | 0.399 0.025 DBMET00255 0.242 0.156 DBMET01957 0.468 0.008 DBMET01958 0.351 0.049 DBMET01959 0.284 0.109 DBMET00254 0.377 0.034 DBMET00314 0.335 0.06 DBMET01961 | DBMET01958 | |
| 0.225 | 0.005 | 0.285 | Histamine H2 receptor antagonist | 0.285 0.004 DBMET00255 0.098 0.036 DBMET01957 0.099 0.035 DBMET01958 0.162 0.008 DBMET01959 0.144 0.011 DBMET00254 0.179 0.006 DBMET00314 0.076 0.073 DBMET01961 | DBMET00255 | |
| 0.228 | 0.008 | 0.228 | Sigma receptor antagonist | 0.108 0.015 DBMET00255 0.05 0.035 DBMET01958 0.083 0.02 DBMET01959 0.126 0.013 DBMET00254 0.075 0.022 DBMET00314 | ||
| 0.23 | 0.011 | 0.23 | Falcipain 3 inhibitor | 0.2 0.018 DBMET00255 0.106 0.064 DBMET01957 0.191 0.02 DBMET01958 0.17 0.028 DBMET01959 0.205 0.016 DBMET00254 0.17 0.028 DBMET00314 0.095 0.076 DBMET01961 | ||
| 0.242 | 0.023 | 0.325 | NADPH oxidase inhibitor | 0.137 0.065 DBMET00255 0.308 0.011 DBMET01958 0.177 0.042 DBMET01959 0.325 0.009 DBMET00254 0.211 0.031 DBMET00314 0.164 0.047 DBMET01961 0.253 0.02 DBMET00680 0.143 0.059 DBMET01956 | DBMET00254 | |
| 0.23 | 0.012 | 0.259 | 5 Hydroxytryptamine agonist | 0.228 0.012 DBMET00255 0.259 0.01 DBMET01958 0.227 0.012 DBMET01959 0.083 0.04 DBMET00254 0.09 0.037 DBMET00314 | DBMET01958 | |
| 0.238 | 0.02 | 0.279 | Adenylate cyclase inhibitor | 0.189 0.028 DBMET00255 0.175 0.032 DBMET01958 0.276 0.016 DBMET01959 0.279 0.016 DBMET00254 0.231 0.021 DBMET00314 0.25 0.019 DBMET01961 0.174 0.032 DBMET00680 0.149 0.046 DBMET01956 | DBMET00254 | |
| 0.224 | 0.006 | 0.267 | Adenylate cyclase stimulant | 0.238 0.005 DBMET00255 0.152 0.06 DBMET01957 0.197 0.015 DBMET01958 0.234 0.005 DBMET01959 0.251 0.004 DBMET00254 0.267 0.004 DBMET00314 0.242 0.004 DBMET01961 0.183 0.024 DBMET00680 0.194 0.016 DBMET01956 | DBMET00314 | |
| 0.229 | 0.011 | 0.669 | Mediator release inhibitor | 0.193 0.016 DBMET00255 0.099 0.071 DBMET01958 0.217 0.012 DBMET01959 0.292 0.008 DBMET00254 0.235 0.011 DBMET00314 0.177 0.019 DBMET01961 0.669 0.003 DBMET00680 0.6 0.004 DBMET01956 | DBMET00680 | |
| 0.225 | 0.008 | 0.25 | MAP3K9 inhibitor | 0.219 0.009 DBMET00255 0.187 0.022 DBMET01957 0.25 0.005 DBMET01958 0.235 0.007 DBMET01959 0.211 0.011 DBMET00254 0.207 0.013 DBMET00314 0.188 0.021 DBMET01961 0.125 0.104 DBMET00680 0.127 0.101 DBMET01956 | DBMET01958 | |
| 0.227 | 0.014 | 0.227 | Dopamine D2 antagonist | 0.177 0.019 DBMET00255 0.101 0.032 DBMET01958 0.12 0.027 DBMET01959 0.226 0.014 DBMET00254 0.177 0.019 DBMET00314 | ||
| 0.26 | 0.048 | 0.367 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.229 0.059 DBMET00255 0.367 0.02 DBMET01958 0.328 0.029 DBMET01959 0.206 0.072 DBMET00254 0.192 0.083 DBMET00314 0.172 0.102 DBMET01961 | DBMET01958 | |
| 0.268 | 0.06 | 0.39 | Vasodilator | 0.215 0.093 DBMET00255 0.16 0.143 DBMET01958 0.168 0.134 DBMET01959 0.282 0.055 DBMET00254 0.237 0.077 DBMET00314 0.266 0.061 DBMET01961 0.39 0.025 DBMET00680 0.353 0.032 DBMET01956 | DBMET00680 | |
| 0.212 | 0.005 | 0.238 | Interferon agonist | 0.129 0.014 DBMET00255 0.086 0.044 DBMET01957 0.086 0.043 DBMET01958 0.202 0.006 DBMET01959 0.161 0.009 DBMET00254 0.106 0.024 DBMET00314 0.187 0.007 DBMET01961 0.238 0.005 DBMET00680 0.146 0.011 DBMET01956 | DBMET00680 | |
| 0.214 | 0.009 | 0.214 | Dopamine agonist | 0.209 0.009 DBMET00255 0.166 0.013 DBMET01958 0.188 0.011 DBMET01959 0.211 0.009 DBMET00254 0.207 0.009 DBMET00314 0.058 0.054 DBMET01961 0.063 0.049 DBMET00680 0.068 0.046 DBMET01956 | ||
| 0.215 | 0.01 | 0.215 | Dopamine D3 antagonist | 0.185 0.012 DBMET00255 0.061 0.044 DBMET01957 0.098 0.025 DBMET01958 0.093 0.027 DBMET01959 0.177 0.012 DBMET00254 0.15 0.015 DBMET00314 | ||
| 0.226 | 0.021 | 0.372 | ATPase inhibitor | 0.212 0.028 DBMET00255 0.208 0.031 DBMET01958 0.142 0.115 DBMET01959 0.226 0.021 DBMET00254 0.212 0.028 DBMET00314 0.138 0.124 DBMET01961 0.372 0.004 DBMET00680 0.351 0.004 DBMET01956 | DBMET00680 | |
| 0.215 | 0.014 | 0.243 | Neuropeptide Y1 antagonist | 0.226 0.012 DBMET00255 0.159 0.052 DBMET01957 0.169 0.04 DBMET01958 0.243 0.009 DBMET01959 0.221 0.013 DBMET00254 0.232 0.011 DBMET00314 0.157 0.055 DBMET01961 | DBMET01959 | |
| 0.256 | 0.064 | 0.256 | Potassium channel blocker | 0.177 0.109 DBMET01957 | ||
| 0.24 | 0.048 | 0.375 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.145 0.092 DBMET00255 0.375 0.022 DBMET01958 0.346 0.027 DBMET01959 0.183 0.072 DBMET00254 0.121 0.115 DBMET00314 0.14 0.096 DBMET01961 | DBMET01958 | |
| 0.204 | 0.012 | 0.335 | GABA C receptor antagonist | 0.173 0.02 DBMET00255 0.093 0.09 DBMET01957 0.335 0.004 DBMET01958 0.297 0.004 DBMET01959 0.182 0.017 DBMET00254 0.155 0.027 DBMET00314 0.198 0.013 DBMET01961 | DBMET01958 | |
| 0.302 | 0.113 | 0.327 | Calpain 2 inhibitor | 0.327 0.098 DBMET00255 0.305 0.111 DBMET01958 0.268 0.137 DBMET01959 0.211 0.178 DBMET00254 0.237 0.159 DBMET00314 | DBMET00255 | |
| 0.198 | 0.012 | 0.207 | Protein kinase C mu inhibitor | 0.188 0.014 DBMET00255 0.083 0.076 DBMET01957 0.159 0.022 DBMET01958 0.207 0.011 DBMET01959 0.162 0.021 DBMET00254 0.158 0.023 DBMET00314 0.164 0.02 DBMET01961 | DBMET01959 | |
| 0.243 | 0.059 | 0.374 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.267 0.052 DBMET00255 0.308 0.041 DBMET01958 0.374 0.022 DBMET01959 0.176 0.091 DBMET00254 0.191 0.08 DBMET00314 0.151 0.11 DBMET01961 | DBMET01959 | |
| 0.188 | 0.005 | 0.188 | Protein kinase C eta inhibitor | 0.172 0.005 DBMET00255 0.096 0.018 DBMET01957 0.109 0.015 DBMET01958 0.181 0.005 DBMET01959 0.173 0.005 DBMET00254 0.16 0.007 DBMET00314 0.155 0.007 DBMET01961 0.115 0.013 DBMET00680 0.108 0.015 DBMET01956 | ||
| 0.189 | 0.006 | 0.189 | Calcium channel L-type blocker | 0.144 0.011 DBMET00255 0.064 0.062 DBMET01957 0.079 0.04 DBMET01958 0.104 0.023 DBMET01959 0.129 0.014 DBMET00254 0.096 0.027 DBMET00314 | ||
| 0.186 | 0.004 | 0.186 | Protein kinase C beta inhibitor | 0.158 0.004 DBMET00255 0.078 0.033 DBMET01957 0.119 0.007 DBMET01958 0.156 0.004 DBMET01959 0.184 0.004 DBMET00254 0.156 0.004 DBMET00314 0.137 0.005 DBMET01961 0.101 0.013 DBMET00680 0.084 0.025 DBMET01956 | ||
| 0.206 | 0.026 | 0.402 | GABA C receptor rho-2 antagonist | 0.254 0.011 DBMET00255 0.158 0.063 DBMET01957 0.402 0.003 DBMET01958 0.205 0.026 DBMET01959 0.202 0.028 DBMET00254 0.249 0.012 DBMET00314 0.125 0.116 DBMET01961 | DBMET01958 | |
| 0.186 | 0.007 | 0.186 | Dopamine D4 agonist | 0.153 0.009 DBMET00255 0.061 0.026 DBMET01957 0.102 0.014 DBMET01958 0.13 0.011 DBMET01959 0.083 0.019 DBMET00254 0.077 0.02 DBMET00314 | ||
| 0.184 | 0.007 | 0.212 | CXC chemokine receptor antagonist | 0.133 0.014 DBMET00255 0.139 0.013 DBMET01958 0.212 0.005 DBMET01959 0.125 0.016 DBMET00254 0.092 0.029 DBMET00314 0.075 0.043 DBMET01961 | DBMET01959 | |
| 0.181 | 0.005 | 0.181 | Acetylcholine M5 receptor antagonist | 0.142 0.009 DBMET00255 0.063 0.038 DBMET01957 0.067 0.034 DBMET01958 0.096 0.019 DBMET01959 0.142 0.009 DBMET00254 0.114 0.014 DBMET00314 | ||
| 0.246 | 0.07 | 0.376 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.26 0.054 DBMET00255 0.192 0.189 DBMET01957 0.376 0.008 DBMET01958 0.275 0.04 DBMET01959 0.208 0.143 DBMET00254 0.222 0.111 DBMET00314 0.198 0.172 DBMET01961 | DBMET01958 | |
| 0.178 | 0.004 | 0.178 | 5 Hydroxytryptamine 3B antagonist | 0.12 0.004 DBMET00255 0.041 0.02 DBMET01957 0.072 0.008 DBMET01958 0.083 0.006 DBMET01959 0.075 0.008 DBMET00254 0.054 0.013 DBMET00314 | ||
| 0.21 | 0.038 | 0.293 | MAO inhibitor | 0.166 0.053 DBMET00255 0.153 0.059 DBMET01958 0.176 0.049 DBMET01959 0.293 0.021 DBMET00254 0.24 0.03 DBMET00314 | DBMET00254 | |
| 0.191 | 0.019 | 0.191 | Calcium channel (voltage-sensitive) blocker | 0.155 0.031 DBMET00255 0.112 0.067 DBMET01959 0.114 0.065 DBMET00254 | ||
| 0.199 | 0.029 | 0.299 | MAO A inhibitor | 0.184 0.033 DBMET00255 0.181 0.033 DBMET01958 0.151 0.041 DBMET01959 0.299 0.015 DBMET00254 0.281 0.017 DBMET00314 | DBMET00254 | |
| 0.2 | 0.03 | 0.2 | Toll-Like receptor antagonist | 0.192 0.033 DBMET00255 0.167 0.045 DBMET01958 0.159 0.049 DBMET01959 0.193 0.033 DBMET00254 0.185 0.036 DBMET00314 | ||
| 0.211 | 0.042 | 0.212 | Antipruritic | 0.212 0.041 DBMET00255 0.211 0.042 DBMET01959 0.204 0.046 DBMET00254 0.206 0.045 DBMET00314 | DBMET00255 | |
| 0.313 | 0.146 | 0.616 | Calcium channel L-type activator | 0.576 0.009 DBMET00255 0.284 0.171 DBMET01957 0.616 0.005 DBMET01958 0.349 0.118 DBMET01959 0.408 0.076 DBMET00254 0.571 0.009 DBMET00314 0.231 0.228 DBMET01961 0.452 0.05 DBMET01956 | DBMET01958 | |
| 0.182 | 0.016 | 0.182 | Calcium antagonist | 0.087 0.057 DBMET00255 0.098 0.049 DBMET01958 0.074 0.069 DBMET01959 0.1 0.048 DBMET00254 | ||
| 0.239 | 0.076 | 0.456 | Antiamyloidogenic | 0.254 0.069 DBMET00255 0.183 0.112 DBMET01958 0.242 0.074 DBMET01959 0.341 0.041 DBMET00254 0.358 0.037 DBMET00314 0.206 0.096 DBMET01961 0.442 0.023 DBMET00680 0.456 0.02 DBMET01956 | DBMET01956 | |
| 0.176 | 0.015 | 0.23 | Nitric-oxide synthase inhibitor | 0.23 0.006 DBMET00255 0.165 0.017 DBMET01958 0.227 0.006 DBMET01959 0.115 0.041 DBMET00254 0.163 0.018 DBMET00314 0.189 0.011 DBMET01961 | DBMET00255 | |
| 0.164 | 0.006 | 0.164 | Dopamine D5 antagonist | 0.072 0.014 DBMET00255 0.078 0.012 DBMET01957 0.061 0.019 DBMET01958 0.077 0.013 DBMET01959 0.16 0.006 DBMET00254 0.081 0.012 DBMET00314 | ||
| 0.216 | 0.058 | 0.281 | Focal adhesion kinase 2 inhibitor | 0.18 0.088 DBMET00255 0.281 0.023 DBMET01958 0.166 0.105 DBMET01959 0.154 0.125 DBMET00254 | DBMET01958 | |
| 0.161 | 0.004 | 0.161 | Sigma 2 receptor antagonist | 0.089 0.005 DBMET00255 0.028 0.018 DBMET01957 0.074 0.006 DBMET01959 0.157 0.004 DBMET00254 0.086 0.005 DBMET00314 0.03 0.016 DBMET01961 | ||
| 0.166 | 0.008 | 0.224 | Protein kinase C alpha inhibitor | 0.132 0.013 DBMET00255 0.224 0.005 DBMET01957 0.081 0.033 DBMET01958 0.172 0.008 DBMET01959 0.122 0.015 DBMET00254 0.1 0.022 DBMET00314 0.109 0.019 DBMET01961 | DBMET01957 | |
| 0.216 | 0.06 | 0.276 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.225 0.055 DBMET01958 0.176 0.099 DBMET01959 0.276 0.032 DBMET00254 0.178 0.096 DBMET00314 0.189 0.082 DBMET01961 0.198 0.074 DBMET00680 | DBMET00254 | |
| 0.165 | 0.01 | 0.176 | Acetylcholine release stimulant | 0.176 0.007 DBMET00255 0.124 0.043 DBMET01957 0.16 0.012 DBMET01958 0.142 0.022 DBMET01959 0.132 0.032 DBMET00254 0.14 0.024 DBMET00314 0.141 0.023 DBMET00680 0.149 0.017 DBMET01956 | DBMET00255 | |
| 0.173 | 0.018 | 0.206 | Neuropeptide Y antagonist | 0.159 0.02 DBMET00255 0.134 0.025 DBMET01958 0.206 0.014 DBMET01959 0.112 0.033 DBMET00254 0.106 0.037 DBMET00314 | DBMET01959 | |
| 0.252 | 0.099 | 0.383 | Hypoxia-inducible factor 1 alpha inhibitor | 0.233 0.116 DBMET00255 0.276 0.079 DBMET01957 0.246 0.104 DBMET01958 0.192 0.162 DBMET01959 0.347 0.046 DBMET00254 0.323 0.055 DBMET00314 0.383 0.035 DBMET00680 0.358 0.042 DBMET01956 | DBMET00680 | |
| 0.164 | 0.013 | 0.192 | 5 Hydroxytryptamine 1 agonist | 0.139 0.015 DBMET00255 0.192 0.011 DBMET01958 0.094 0.022 DBMET01959 0.052 0.037 DBMET00254 0.049 0.038 DBMET00314 | DBMET01958 | |
| 0.153 | 0.004 | 0.153 | 5 Hydroxytryptamine 7 agonist | 0.118 0.005 DBMET00255 0.067 0.022 DBMET01957 0.145 0.004 DBMET01958 0.132 0.005 DBMET01959 0.147 0.004 DBMET00254 0.114 0.005 DBMET00314 0.059 0.033 DBMET01961 | ||
| 0.156 | 0.01 | 0.171 | Acetylcholine M3 receptor antagonist | 0.118 0.014 DBMET00255 0.086 0.023 DBMET01959 0.171 0.009 DBMET00254 0.135 0.013 DBMET00314 0.072 0.03 DBMET01961 | DBMET00254 | |
| 0.261 | 0.117 | 0.269 | Thyroid hormone antagonist | 0.186 0.174 DBMET01958 0.269 0.111 DBMET00254 | DBMET00254 | |
| 0.153 | 0.009 | 0.153 | 5 Hydroxytryptamine 3 antagonist | 0.105 0.016 DBMET00255 0.092 0.02 DBMET01958 0.109 0.015 DBMET01959 0.052 0.046 DBMET00254 | ||
| 0.175 | 0.033 | 0.296 | Topoisomerase I inhibitor | 0.23 0.02 DBMET01957 0.097 0.073 DBMET01958 0.118 0.057 DBMET01959 0.233 0.019 DBMET00254 0.151 0.041 DBMET00314 0.113 0.06 DBMET01961 0.296 0.011 DBMET00680 0.242 0.018 DBMET01956 | DBMET00680 | |
| 0.149 | 0.006 | 0.155 | Dopamine D2 agonist | 0.126 0.008 DBMET00255 0.106 0.01 DBMET01958 0.117 0.009 DBMET01959 0.155 0.006 DBMET00254 0.134 0.007 DBMET00314 0.069 0.017 DBMET00680 0.066 0.019 DBMET01956 | DBMET00254 | |
| 0.156 | 0.015 | 0.234 | Alpha adrenoreceptor agonist | 0.234 0.006 DBMET00255 0.191 0.009 DBMET01958 0.165 0.014 DBMET01959 0.143 0.017 DBMET00254 0.214 0.007 DBMET00314 | DBMET00255 | |
| 0.203 | 0.062 | 0.212 | P-glycoprotein inhibitor | 0.178 0.082 DBMET00255 0.139 0.134 DBMET01959 0.212 0.057 DBMET00254 0.189 0.071 DBMET00314 0.166 0.095 DBMET01961 0.206 0.06 DBMET00680 0.192 0.07 DBMET01956 | DBMET00254 | |
| 0.163 | 0.022 | 0.33 | DNA repair enzyme inhibitor | 0.144 0.037 DBMET00255 0.208 0.008 DBMET01957 0.147 0.034 DBMET01958 0.136 0.046 DBMET01959 0.157 0.026 DBMET00254 0.138 0.044 DBMET00314 0.116 0.081 DBMET01961 0.33 0.004 DBMET00680 0.263 0.005 DBMET01956 | DBMET00680 | |
| 0.258 | 0.119 | 0.592 | Cholesterol antagonist | 0.195 0.169 DBMET00255 0.321 0.078 DBMET01958 0.196 0.168 DBMET01959 0.308 0.086 DBMET00254 0.249 0.126 DBMET00314 0.247 0.128 DBMET01961 0.592 0.02 DBMET00680 0.514 0.03 DBMET01956 | DBMET00680 | |
| 0.162 | 0.023 | 0.162 | Acetylcholine agonist | 0.151 0.025 DBMET00255 0.116 0.038 DBMET01958 | ||
| 0.145 | 0.007 | 0.145 | 5 Hydroxytryptamine 6 antagonist | 0.117 0.011 DBMET00255 0.1 0.015 DBMET01958 0.101 0.014 DBMET01959 0.084 0.021 DBMET00254 0.066 0.032 DBMET00314 | ||
| 0.189 | 0.051 | 0.337 | Protein kinase C nu inhibitor | 0.156 0.066 DBMET00255 0.231 0.038 DBMET01958 0.299 0.024 DBMET01959 0.139 0.076 DBMET00254 0.123 0.089 DBMET00314 0.337 0.018 DBMET01961 | DBMET01961 | |
| 0.256 | 0.121 | 0.711 | Antithrombotic | 0.273 0.108 DBMET00255 0.255 0.122 DBMET01958 0.298 0.089 DBMET01959 0.272 0.109 DBMET00254 0.287 0.097 DBMET00314 0.269 0.111 DBMET01961 0.694 0.009 DBMET00680 0.711 0.008 DBMET01956 | DBMET01956 | |
| 0.251 | 0.118 | 0.251 | Thyroid hormone beta antagonist | 0.181 0.172 DBMET01958 0.251 0.118 DBMET00254 | ||
| 0.226 | 0.093 | 0.54 | Superoxide dismutase inhibitor | 0.26 0.068 DBMET00255 0.185 0.135 DBMET01957 0.422 0.023 DBMET01958 0.54 0.01 DBMET01959 0.278 0.059 DBMET00254 0.327 0.042 DBMET00314 0.446 0.019 DBMET01961 | DBMET01959 | |
| 0.143 | 0.011 | 0.143 | Acetylcholine muscarinic agonist | 0.075 0.024 DBMET00255 0.048 0.046 DBMET01957 0.073 0.025 DBMET01958 0.048 0.046 DBMET01961 | ||
| 0.158 | 0.026 | 0.174 | Ca2+-transporting ATPase inhibitor | 0.147 0.049 DBMET00255 0.145 0.056 DBMET01957 0.174 0.01 DBMET01958 0.159 0.026 DBMET01959 0.151 0.04 DBMET00254 0.141 0.071 DBMET00314 0.164 0.019 DBMET01961 0.147 0.051 DBMET00680 0.136 0.089 DBMET01956 | DBMET01958 | |
| 0.142 | 0.01 | 0.377 | Adrenaline uptake inhibitor | 0.283 0.004 DBMET00255 0.377 0.004 DBMET01957 0.054 0.052 DBMET01958 0.071 0.034 DBMET01959 0.09 0.022 DBMET00254 0.188 0.007 DBMET00314 0.067 0.037 DBMET01961 0.069 0.035 DBMET01956 | DBMET01957 | |
| 0.231 | 0.102 | 0.413 | 5 Hydroxytryptamine uptake stimulant | 0.229 0.104 DBMET00255 0.413 0.012 DBMET01958 0.302 0.044 DBMET01959 0.227 0.108 DBMET00254 0.225 0.11 DBMET00314 0.246 0.085 DBMET01961 | DBMET01958 | |
| 0.205 | 0.076 | 0.373 | DNA methylase inhibitor | 0.141 0.126 DBMET00255 0.178 0.095 DBMET01958 0.197 0.081 DBMET01959 0.252 0.047 DBMET00254 0.194 0.083 DBMET00314 0.181 0.092 DBMET01961 0.373 0.013 DBMET00680 0.312 0.025 DBMET01956 | DBMET00680 | |
| 0.134 | 0.009 | 0.134 | Acetylcholine M1 receptor agonist | 0.052 0.025 DBMET00255 0.062 0.021 DBMET01958 | ||
| 0.154 | 0.032 | 0.205 | Interleukin 8 antagonist | 0.184 0.017 DBMET00255 0.205 0.011 DBMET01958 0.181 0.019 DBMET01959 0.173 0.022 DBMET00254 0.204 0.012 DBMET00314 0.132 0.048 DBMET01961 | DBMET01958 | |
| 0.128 | 0.006 | 0.141 | Interferon inducer | 0.099 0.013 DBMET00255 0.068 0.038 DBMET01957 0.072 0.032 DBMET01958 0.141 0.005 DBMET01959 0.1 0.013 DBMET00254 0.078 0.026 DBMET00314 0.135 0.005 DBMET01961 0.131 0.006 DBMET00680 0.101 0.012 DBMET01956 | DBMET01959 | |
| 0.126 | 0.004 | 0.126 | 5 Hydroxytryptamine 4 antagonist | 0.124 0.004 DBMET00255 0.053 0.032 DBMET01957 0.067 0.019 DBMET01958 0.12 0.004 DBMET01959 0.092 0.009 DBMET00254 0.091 0.009 DBMET00314 0.086 0.011 DBMET01961 | ||
| 0.163 | 0.044 | 0.316 | Topoisomerase II inhibitor | 0.228 0.028 DBMET01957 0.106 0.08 DBMET01959 0.25 0.024 DBMET00254 0.157 0.046 DBMET00314 0.101 0.085 DBMET01961 0.316 0.016 DBMET00680 0.255 0.024 DBMET01956 | DBMET00680 | |
| 0.12 | 0.003 | 0.12 | Adenylate cyclase 1 inhibitor | 0.106 0.004 DBMET00255 0.057 0.02 DBMET01957 0.104 0.004 DBMET01958 0.105 0.004 DBMET01959 0.112 0.004 DBMET00254 0.096 0.005 DBMET00314 0.095 0.005 DBMET01961 | ||
| 0.126 | 0.009 | 0.143 | Protein kinase C epsilon inhibitor | 0.102 0.012 DBMET00255 0.059 0.032 DBMET01958 0.143 0.007 DBMET01959 0.087 0.016 DBMET00254 0.075 0.021 DBMET00314 0.081 0.019 DBMET01961 | DBMET01959 | |
| 0.157 | 0.041 | 0.164 | Pregnane X receptor agonist | 0.14 0.073 DBMET00255 0.125 0.116 DBMET01957 0.164 0.032 DBMET01958 0.142 0.069 DBMET01959 0.15 0.053 DBMET00254 0.133 0.093 DBMET00314 0.134 0.088 DBMET01961 | DBMET01958 | |
| 0.141 | 0.026 | 0.31 | GABA C receptor rho-1 antagonist | 0.196 0.009 DBMET00255 0.099 0.063 DBMET01957 0.31 0.003 DBMET01958 0.267 0.004 DBMET01959 0.122 0.038 DBMET00254 0.172 0.014 DBMET00314 0.172 0.014 DBMET01961 | DBMET01958 | |
| 0.157 | 0.043 | 0.349 | Alkylator | 0.158 0.043 DBMET00255 0.219 0.021 DBMET01957 0.126 0.063 DBMET01958 0.155 0.044 DBMET01959 0.177 0.034 DBMET00254 0.178 0.034 DBMET00314 0.182 0.032 DBMET01961 0.348 0.01 DBMET00680 0.349 0.01 DBMET01956 | DBMET01956 | |
| 0.127 | 0.013 | 0.127 | Dopamine uptake inhibitor | 0.124 0.014 DBMET00255 0.052 0.046 DBMET01958 0.068 0.032 DBMET01959 0.088 0.022 DBMET00254 0.086 0.023 DBMET00314 0.064 0.034 DBMET01961 | ||
| 0.118 | 0.005 | 0.13 | 5 Hydroxytryptamine 1B agonist | 0.13 0.005 DBMET00255 0.118 0.005 DBMET01958 0.101 0.007 DBMET01959 0.084 0.011 DBMET00254 0.093 0.008 DBMET00314 0.048 0.046 DBMET01961 | DBMET00255 | |
| 0.193 | 0.084 | 0.285 | Neurotrophic factor enhancer | 0.211 0.067 DBMET00255 0.285 0.023 DBMET01958 0.207 0.07 DBMET01959 0.253 0.037 DBMET00254 0.27 0.028 DBMET00314 0.219 0.06 DBMET01961 0.258 0.034 DBMET00680 0.276 0.026 DBMET01956 | DBMET01958 | |
| 0.119 | 0.01 | 0.168 | Beta 3 adrenoreceptor antagonist | 0.124 0.009 DBMET00255 0.117 0.01 DBMET01958 0.073 0.03 DBMET01959 0.16 0.005 DBMET00254 0.168 0.005 DBMET00314 | DBMET00314 | |
| 0.124 | 0.016 | 0.195 | Glycine receptor antagonist | 0.1 0.032 DBMET00255 0.195 0.004 DBMET01958 0.09 0.042 DBMET01959 0.101 0.031 DBMET00254 0.079 0.058 DBMET00314 0.109 0.025 DBMET01961 0.152 0.007 DBMET00680 0.129 0.014 DBMET01956 | DBMET01958 | |
| 0.127 | 0.02 | 0.178 | Hematopoietic | 0.119 0.023 DBMET00255 0.178 0.012 DBMET01959 0.108 0.029 DBMET00254 0.105 0.031 DBMET00314 0.11 0.028 DBMET01961 | DBMET01959 | |
| 0.182 | 0.079 | 0.341 | DNA methyltransferase I inhibitor | 0.131 0.128 DBMET00255 0.162 0.092 DBMET01958 0.145 0.109 DBMET01959 0.252 0.046 DBMET00254 0.179 0.08 DBMET00314 0.135 0.122 DBMET01961 0.341 0.015 DBMET00680 0.29 0.03 DBMET01956 | DBMET00680 | |
| 0.15 | 0.047 | 0.164 | Heat shock protein 70 antagonist | 0.136 0.092 DBMET00255 0.161 0.026 DBMET01958 0.155 0.035 DBMET01959 0.159 0.029 DBMET00254 0.144 0.061 DBMET00314 0.144 0.061 DBMET01961 0.164 0.023 DBMET00680 0.148 0.049 DBMET01956 | DBMET00680 | |
| 0.217 | 0.115 | 0.354 | Transcription factor STAT inhibitor | 0.212 0.122 DBMET00255 0.299 0.057 DBMET01958 0.354 0.033 DBMET01959 0.232 0.1 DBMET00254 0.226 0.106 DBMET00314 0.279 0.068 DBMET01961 | DBMET01959 | |
| 0.109 | 0.008 | 0.128 | 5 Hydroxytryptamine 2 agonist | 0.124 0.006 DBMET00255 0.128 0.006 DBMET01958 0.121 0.007 DBMET01959 0.076 0.017 DBMET00254 0.085 0.013 DBMET00314 0.049 0.039 DBMET01961 | DBMET01958 | |
| 0.141 | 0.04 | 0.243 | 5 Hydroxytryptamine 3A agonist | 0.179 0.022 DBMET00255 0.243 0.006 DBMET01958 0.234 0.007 DBMET01959 0.129 0.049 DBMET00254 0.166 0.027 DBMET00314 0.109 0.066 DBMET01961 | DBMET01958 | |
| 0.211 | 0.111 | 0.394 | Interleukin agonist | 0.276 0.061 DBMET00255 0.292 0.052 DBMET01958 0.346 0.03 DBMET01959 0.187 0.132 DBMET00254 0.255 0.075 DBMET00314 0.363 0.026 DBMET01961 0.324 0.037 DBMET00680 0.394 0.02 DBMET01956 | DBMET01956 | |
| 0.132 | 0.033 | 0.225 | Creatine kinase inhibitor | 0.111 0.048 DBMET00255 0.105 0.054 DBMET01957 0.197 0.011 DBMET01958 0.174 0.016 DBMET01959 0.225 0.007 DBMET00254 0.194 0.011 DBMET00314 0.188 0.013 DBMET01961 | DBMET00254 | |
| 0.103 | 0.006 | 0.103 | Sigma 1 receptor antagonist | 0.049 0.01 DBMET00255 0.035 0.014 DBMET01959 0.045 0.011 DBMET00254 0.03 0.017 DBMET00314 | ||
| 0.124 | 0.027 | 0.197 | Glutamate (mGluR7) agonist | 0.197 0.005 DBMET00255 0.095 0.071 DBMET01957 0.165 0.008 DBMET01958 0.144 0.014 DBMET01959 0.13 0.022 DBMET00314 0.098 0.064 DBMET01961 | DBMET00255 | |
| 0.208 | 0.111 | 0.359 | DNA synthesis inhibitor | 0.171 0.167 DBMET00255 0.26 0.06 DBMET01958 0.197 0.128 DBMET01959 0.21 0.109 DBMET00254 0.173 0.163 DBMET00314 0.203 0.119 DBMET01961 0.359 0.028 DBMET00680 0.312 0.04 DBMET01956 | DBMET00680 | |
| 0.105 | 0.009 | 0.105 | Potassium channel (Ca-activated) blocker | 0.084 0.015 DBMET00255 0.084 0.016 DBMET01958 0.08 0.018 DBMET01959 0.068 0.029 DBMET00254 0.058 0.047 DBMET00314 | ||
| 0.104 | 0.007 | 0.288 | Kinesin-like protein 1 inhibitor | 0.038 0.025 DBMET00255 0.288 0.003 DBMET01957 0.124 0.005 DBMET01958 0.185 0.004 DBMET01959 0.096 0.008 DBMET00254 0.041 0.021 DBMET00314 0.092 0.009 DBMET01961 | DBMET01957 | |
| 0.104 | 0.007 | 0.288 | Kinesin antagonist | 0.038 0.025 DBMET00255 0.288 0.003 DBMET01957 0.124 0.005 DBMET01958 0.185 0.004 DBMET01959 0.096 0.008 DBMET00254 0.041 0.021 DBMET00314 0.092 0.009 DBMET01961 | DBMET01957 | |
| 0.112 | 0.017 | 0.112 | Viral attachment inhibitor | 0.09 0.033 DBMET00255 0.099 0.024 DBMET01959 0.081 0.046 DBMET00254 | ||
| 0.108 | 0.014 | 0.108 | Calcium channel T-type blocker | 0.066 0.031 DBMET00255 0.06 0.038 DBMET01959 0.053 0.049 DBMET00254 | ||
| 0.132 | 0.039 | 0.132 | Sphingosine 1-phosphate receptor 2 agonist | 0.125 0.047 DBMET01958 0.128 0.043 DBMET00254 0.104 0.091 DBMET00314 0.128 0.044 DBMET01961 | ||
| 0.164 | 0.072 | 0.204 | Arachidonic acid antagonist | 0.204 0.029 DBMET01958 0.184 0.05 DBMET00254 | DBMET01958 | |
| 0.133 | 0.04 | 0.203 | Transcription factor STAT6 inhibitor | 0.136 0.037 DBMET00255 0.146 0.026 DBMET01958 0.203 0.007 DBMET01959 0.139 0.033 DBMET00254 0.143 0.029 DBMET00314 0.149 0.024 DBMET01961 | DBMET01959 | |
| 0.131 | 0.041 | 0.145 | Chemokine receptor antagonist | 0.105 0.058 DBMET00255 0.145 0.034 DBMET01959 | DBMET01959 | |
| 0.189 | 0.099 | 0.257 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.238 0.067 DBMET01958 0.257 0.057 DBMET01959 0.167 0.122 DBMET00254 | DBMET01959 | |
| 0.096 | 0.007 | 0.096 | Potassium channel small-conductance Ca-activated blocker | 0.095 0.007 DBMET00255 0.091 0.008 DBMET01958 0.063 0.016 DBMET01959 0.049 0.026 DBMET00254 0.048 0.026 DBMET00314 | ||
| 0.133 | 0.044 | 0.192 | MAO B inhibitor | 0.081 0.075 DBMET01958 0.104 0.058 DBMET01959 0.192 0.026 DBMET00254 0.124 0.049 DBMET00314 | DBMET00254 | |
| 0.105 | 0.017 | 0.13 | Acetylcholine M5 receptor agonist | 0.08 0.034 DBMET00255 0.065 0.049 DBMET01957 0.13 0.008 DBMET01958 0.093 0.024 DBMET01959 0.065 0.049 DBMET00254 | DBMET01958 | |
| 0.119 | 0.032 | 0.148 | Lanosterol 14 alpha demethylase inhibitor | 0.109 0.043 DBMET00255 0.132 0.021 DBMET01958 0.145 0.013 DBMET01959 0.106 0.047 DBMET00254 0.096 0.062 DBMET00314 0.148 0.012 DBMET01961 | DBMET01961 | |
| 0.176 | 0.09 | 0.428 | Non-steroidal antiinflammatory agent | 0.167 0.097 DBMET00255 0.159 0.105 DBMET01958 0.177 0.09 DBMET01959 0.197 0.073 DBMET00254 0.19 0.08 DBMET00314 0.428 0.01 DBMET00680 0.417 0.012 DBMET01956 | DBMET00680 | |
| 0.111 | 0.025 | 0.139 | Myeloperoxidase inhibitor | 0.114 0.023 DBMET00255 0.113 0.024 DBMET01958 0.139 0.013 DBMET01959 0.122 0.019 DBMET00254 0.127 0.017 DBMET00314 0.091 0.048 DBMET01961 | DBMET01959 | |
| 0.09 | 0.004 | 0.104 | GABA uptake inhibitor | 0.063 0.009 DBMET00255 0.051 0.015 DBMET01957 0.046 0.019 DBMET01958 0.104 0.004 DBMET01959 0.072 0.006 DBMET00254 0.048 0.017 DBMET00314 0.067 0.008 DBMET01961 | DBMET01959 | |
| 0.148 | 0.064 | 0.188 | Sphingosine 1-phosphate receptor 5 antagonist | 0.131 0.097 DBMET00255 0.188 0.018 DBMET01958 0.16 0.046 DBMET01959 0.137 0.085 DBMET00254 | DBMET01958 | |
| 0.104 | 0.02 | 0.137 | Estrogen-related receptor beta agonist | 0.084 0.056 DBMET00255 0.096 0.03 DBMET01958 0.137 0.005 DBMET00254 0.108 0.017 DBMET00314 | DBMET00254 | |
| 0.103 | 0.019 | 0.118 | CC chemokine 5 receptor agonist | 0.089 0.039 DBMET00255 0.118 0.009 DBMET01958 0.087 0.044 DBMET01959 0.118 0.009 DBMET00254 0.102 0.019 DBMET00314 | DBMET00254 | |
| 0.115 | 0.032 | 0.124 | Acetylcholine nicotinic antagonist | 0.124 0.029 DBMET00255 0.094 0.043 DBMET01958 0.102 0.038 DBMET01959 0.086 0.049 DBMET00254 0.092 0.044 DBMET00314 | DBMET00255 | |
| 0.089 | 0.006 | 0.089 | Prolactin release inhibitor | 0.074 0.016 DBMET00255 0.069 0.024 DBMET01957 0.087 0.007 DBMET01958 0.081 0.01 DBMET01959 0.084 0.009 DBMET00254 0.073 0.018 DBMET00314 0.073 0.019 DBMET01961 | ||
| 0.12 | 0.037 | 0.157 | Protein kinase C delta inhibitor | 0.102 0.05 DBMET00255 0.119 0.038 DBMET01958 0.157 0.018 DBMET01959 0.104 0.048 DBMET00254 0.092 0.061 DBMET00314 0.115 0.04 DBMET01961 | DBMET01959 | |
| 0.097 | 0.016 | 0.154 | Alpha 2 adrenoreceptor agonist | 0.142 0.007 DBMET00255 0.154 0.006 DBMET01958 0.112 0.012 DBMET01959 0.081 0.023 DBMET00254 0.121 0.01 DBMET00314 | DBMET01958 | |
| 0.088 | 0.008 | 0.088 | Bcl-xL inhibitor | 0.078 0.012 DBMET00254 | ||
| 0.154 | 0.074 | 0.3 | Diuretic | 0.149 0.078 DBMET00255 0.172 0.059 DBMET01958 0.184 0.051 DBMET01959 0.136 0.089 DBMET00254 0.131 0.093 DBMET00314 0.192 0.047 DBMET01961 0.3 0.022 DBMET00680 0.294 0.023 DBMET01956 | DBMET00680 | |
| 0.099 | 0.02 | 0.106 | Cannabinoid CB1 receptor agonist | 0.1 0.02 DBMET00255 0.082 0.027 DBMET01958 0.106 0.018 DBMET01959 | DBMET01959 | |
| 0.104 | 0.025 | 0.104 | Caspase 7 inhibitor | 0.096 0.033 DBMET00255 0.094 0.036 DBMET01958 0.079 0.064 DBMET01959 0.083 0.055 DBMET00254 0.076 0.071 DBMET00314 | ||
| 0.13 | 0.052 | 0.13 | Calcium channel N-type blocker | 0.121 0.062 DBMET00255 | ||
| 0.108 | 0.032 | 0.135 | Acetylcholine nicotinic agonist | 0.135 0.021 DBMET00255 0.106 0.033 DBMET01958 0.085 0.05 DBMET00314 | DBMET00255 | |
| 0.15 | 0.075 | 0.183 | Cytidine deaminase inhibitor | 0.123 0.097 DBMET00255 0.183 0.055 DBMET01958 | DBMET01958 | |
| 0.093 | 0.018 | 0.093 | Acyl-CoA dehydrogenase inhibitor | 0.054 0.038 DBMET00255 0.065 0.03 DBMET01958 0.056 0.037 DBMET01959 0.053 0.039 DBMET00254 0.061 0.032 DBMET01961 | ||
| 0.094 | 0.019 | 0.13 | Phospholipase D inhibitor | 0.114 0.008 DBMET00255 0.13 0.005 DBMET01958 0.084 0.028 DBMET01959 0.068 0.058 DBMET00254 0.084 0.029 DBMET00314 | DBMET01958 | |
| 0.161 | 0.086 | 0.205 | Phospholipase C inhibitor | 0.198 0.045 DBMET01958 0.193 0.049 DBMET01959 0.185 0.055 DBMET00254 0.15 0.106 DBMET00314 0.205 0.041 DBMET01961 0.159 0.089 DBMET00680 | DBMET01961 | |
| 0.162 | 0.089 | 0.282 | Lipocortins synthesis antagonist | 0.147 0.109 DBMET00255 0.282 0.025 DBMET01958 0.142 0.117 DBMET01959 0.181 0.07 DBMET00254 0.168 0.083 DBMET00314 0.145 0.113 DBMET01961 0.17 0.08 DBMET00680 0.162 0.089 DBMET01956 | DBMET01958 | |
| 0.076 | 0.004 | 0.095 | Histamine H1 receptor agonist | 0.095 0.003 DBMET00255 0.051 0.016 DBMET01957 0.082 0.003 DBMET01958 0.082 0.003 DBMET01959 0.045 0.028 DBMET00254 0.058 0.01 DBMET00314 0.044 0.029 DBMET01961 | DBMET00255 | |
| 0.119 | 0.051 | 0.391 | GABA C receptor agonist | 0.112 0.056 DBMET00255 0.374 0.006 DBMET01958 0.391 0.005 DBMET01959 0.088 0.082 DBMET00254 0.263 0.012 DBMET01961 | DBMET01959 | |
| 0.082 | 0.013 | 0.124 | Histamine agonist | 0.124 0.006 DBMET00255 0.071 0.019 DBMET01958 0.101 0.009 DBMET01959 0.056 0.031 DBMET00314 | DBMET00255 | |
| 0.09 | 0.023 | 0.11 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.082 0.034 DBMET00255 0.11 0.009 DBMET01958 0.1 0.013 DBMET01959 0.081 0.036 DBMET01961 | DBMET01958 | |
| 0.077 | 0.011 | 0.095 | Chemokine receptor agonist | 0.076 0.012 DBMET00255 0.061 0.026 DBMET01958 0.095 0.005 DBMET01959 0.055 0.031 DBMET01961 | DBMET01959 | |
| 0.115 | 0.048 | 0.115 | Gastric antisecretory | 0.114 0.048 DBMET00255 0.114 0.049 DBMET01958 0.104 0.06 DBMET01961 | ||
| 0.103 | 0.037 | 0.12 | Bromodomain-containing protein 2 inhibitor | 0.087 0.06 DBMET00255 0.12 0.023 DBMET01958 | DBMET01958 | |
| 0.08 | 0.015 | 0.085 | Calcium channel P-type blocker | 0.067 0.034 DBMET00255 0.062 0.05 DBMET01957 0.085 0.011 DBMET01958 0.072 0.024 DBMET01959 0.068 0.033 DBMET00254 | DBMET01958 | |
| 0.087 | 0.022 | 0.16 | 5 Hydroxytryptamine 2A agonist | 0.091 0.019 DBMET00255 0.16 0.005 DBMET01958 0.115 0.01 DBMET01959 0.085 0.023 DBMET00254 0.089 0.02 DBMET00314 0.067 0.04 DBMET01961 | DBMET01958 | |
| 0.07 | 0.006 | 0.07 | 5 Hydroxytryptamine 1D agonist | 0.061 0.007 DBMET00255 0.067 0.006 DBMET01958 0.047 0.011 DBMET01959 0.029 0.02 DBMET00254 | ||
| 0.069 | 0.005 | 0.104 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.034 0.031 DBMET00255 0.104 0.004 DBMET01957 0.049 0.012 DBMET00254 | DBMET01957 | |
| 0.077 | 0.014 | 0.119 | Topoisomerase II beta inhibitor | 0.097 0.01 DBMET01958 0.119 0.007 DBMET00254 0.058 0.024 DBMET00314 0.08 0.013 DBMET00680 | DBMET00254 | |
| 0.189 | 0.127 | 0.503 | Immunostimulant | 0.156 0.149 DBMET00255 0.186 0.129 DBMET01958 0.251 0.095 DBMET01959 0.21 0.114 DBMET00254 0.178 0.134 DBMET00314 0.312 0.075 DBMET01961 0.503 0.029 DBMET00680 0.473 0.033 DBMET01956 | DBMET00680 | |
| 0.069 | 0.007 | 0.069 | Benzodiazepine antagonist | 0.05 0.026 DBMET00255 0.069 0.008 DBMET01958 0.046 0.035 DBMET00254 | ||
| 0.102 | 0.04 | 0.148 | Glutamate release inhibitor | 0.111 0.029 DBMET00255 0.148 0.01 DBMET01958 0.118 0.024 DBMET01959 0.09 0.062 DBMET00254 0.098 0.046 DBMET00314 0.084 0.078 DBMET01961 0.096 0.049 DBMET00680 0.105 0.036 DBMET01956 | DBMET01958 | |
| 0.083 | 0.022 | 0.153 | Alpha 1 adrenoreceptor agonist | 0.153 0.009 DBMET00255 0.127 0.012 DBMET01958 0.089 0.02 DBMET01959 0.068 0.029 DBMET00254 0.122 0.012 DBMET00314 | DBMET00255 | |
| 0.076 | 0.017 | 0.076 | Histamine H3 receptor antagonist | 0.06 0.022 DBMET00255 | ||
| 0.071 | 0.012 | 0.071 | Sodium/calcium exchanger inhibitor | 0.048 0.039 DBMET00255 0.048 0.038 DBMET01958 0.049 0.037 DBMET01959 0.059 0.02 DBMET00254 0.049 0.037 DBMET01961 | ||
| 0.133 | 0.076 | 0.136 | Neurotrophic factor | 0.128 0.083 DBMET00254 0.136 0.073 DBMET01961 0.121 0.094 DBMET00680 | DBMET01961 | |
| 0.084 | 0.027 | 0.094 | 5 Hydroxytryptamine 3A antagonist | 0.075 0.036 DBMET00255 0.094 0.02 DBMET01958 0.079 0.032 DBMET01959 | DBMET01958 | |
| 0.07 | 0.012 | 0.084 | Histamine H4 receptor antagonist | 0.079 0.009 DBMET00255 0.069 0.013 DBMET01958 0.084 0.007 DBMET01959 0.045 0.041 DBMET00314 | DBMET01959 | |
| 0.082 | 0.025 | 0.101 | Glutamate (mGluR7) antagonist | 0.065 0.052 DBMET00255 0.101 0.01 DBMET01958 0.086 0.02 DBMET01959 0.077 0.031 DBMET00254 | DBMET01958 | |
| 0.196 | 0.14 | 0.291 | Transcription factor STAT3 inhibitor | 0.188 0.151 DBMET00255 0.291 0.058 DBMET01958 0.274 0.067 DBMET01959 0.203 0.13 DBMET00254 0.195 0.141 DBMET00314 0.212 0.119 DBMET01961 | DBMET01958 | |
| 0.176 | 0.122 | 0.229 | ErbB-1 antagonist | 0.165 0.144 DBMET00255 0.229 0.064 DBMET01958 0.205 0.084 DBMET00254 0.192 0.099 DBMET00314 | DBMET01958 | |
| 0.079 | 0.025 | 0.136 | NMDA 2C receptor antagonist | 0.062 0.043 DBMET00255 0.117 0.011 DBMET01958 0.136 0.008 DBMET01959 0.099 0.016 DBMET00254 0.076 0.028 DBMET00314 0.071 0.032 DBMET01961 | DBMET01959 | |
| 0.084 | 0.033 | 0.085 | Cannabinoid receptor agonist | 0.085 0.033 DBMET00255 0.076 0.037 DBMET01959 | DBMET00255 | |
| 0.066 | 0.016 | 0.072 | Squalene epoxidase inhibitor | 0.055 0.026 DBMET00255 0.049 0.036 DBMET01959 0.072 0.013 DBMET00254 0.06 0.021 DBMET00314 | DBMET00254 | |
| 0.068 | 0.019 | 0.122 | Nicotinic alpha3beta2 receptor antagonist | 0.072 0.017 DBMET00255 0.052 0.039 DBMET01957 0.122 0.005 DBMET01958 | DBMET01958 | |
| 0.053 | 0.005 | 0.053 | Protein kinase C beta II inhibitor | 0.04 0.011 DBMET00255 0.032 0.023 DBMET01958 0.039 0.012 DBMET01959 0.049 0.006 DBMET00254 0.039 0.012 DBMET00314 0.032 0.023 DBMET01961 0.033 0.022 DBMET00680 | ||
| 0.061 | 0.013 | 0.062 | Geranyltranstransferase inhibitor | 0.048 0.025 DBMET00255 0.059 0.014 DBMET01958 0.062 0.012 DBMET01959 0.048 0.025 DBMET00254 | DBMET01959 | |
| 0.067 | 0.019 | 0.083 | Thromboxane synthase inhibitor | 0.083 0.01 DBMET00255 0.053 0.04 DBMET01958 0.07 0.017 DBMET01959 0.06 0.027 DBMET00254 0.074 0.015 DBMET00314 0.063 0.023 DBMET01961 | DBMET00255 | |
| 0.13 | 0.083 | 0.319 | Lipid peroxidase inhibitor | 0.144 0.072 DBMET01958 0.226 0.032 DBMET00254 0.19 0.046 DBMET00314 0.127 0.087 DBMET01961 0.319 0.016 DBMET00680 0.286 0.021 DBMET01956 | DBMET00680 | |
| 0.119 | 0.072 | 0.186 | Aldehyde dehydrogenase inhibitor | 0.132 0.06 DBMET00255 0.148 0.049 DBMET01958 0.174 0.035 DBMET01959 0.167 0.038 DBMET00254 0.186 0.031 DBMET00314 0.12 0.071 DBMET01961 0.14 0.054 DBMET00680 0.155 0.044 DBMET01956 | DBMET00314 | |
| 0.069 | 0.025 | 0.193 | NMDA 2A receptor antagonist | 0.137 0.008 DBMET00255 0.096 0.014 DBMET01958 0.147 0.007 DBMET01959 0.1 0.013 DBMET00254 0.193 0.005 DBMET00314 0.059 0.03 DBMET01961 | DBMET00314 | |
| 0.087 | 0.044 | 0.115 | Na+ K+ transporting ATPase inhibitor | 0.097 0.034 DBMET01958 0.089 0.042 DBMET01959 0.09 0.041 DBMET00254 0.099 0.033 DBMET01961 0.115 0.019 DBMET00680 0.085 0.045 DBMET01956 | DBMET00680 | |
| 0.087 | 0.043 | 0.087 | Ca(v)3.1 blocker | 0.082 0.055 DBMET00254 | ||
| 0.05 | 0.007 | 0.095 | Dopamine autoreceptor agonist | 0.07 0.005 DBMET00255 0.054 0.006 DBMET01958 0.028 0.014 DBMET01959 0.065 0.005 DBMET00254 0.095 0.004 DBMET00314 | DBMET00314 | |
| 0.253 | 0.211 | 0.562 | Apoptosis agonist | 0.235 0.231 DBMET00255 0.261 0.203 DBMET01958 0.379 0.124 DBMET00254 0.354 0.137 DBMET00314 0.28 0.187 DBMET01961 0.562 0.058 DBMET00680 0.541 0.063 DBMET01956 | DBMET00680 | |
| 0.077 | 0.035 | 0.077 | Bcl2 antagonist | 0.069 0.043 DBMET00254 | ||
| 0.095 | 0.053 | 0.095 | Polo-like kinase-1 inhibitor | 0.087 0.068 DBMET00255 0.088 0.066 DBMET01958 0.083 0.077 DBMET01959 | ||
| 0.046 | 0.005 | 0.046 | Protein kinase C beta I inhibitor | 0.042 0.007 DBMET00255 0.033 0.026 DBMET01957 0.035 0.018 DBMET01958 0.039 0.01 DBMET01959 0.044 0.005 DBMET00254 0.041 0.008 DBMET00314 0.036 0.016 DBMET01961 0.039 0.01 DBMET00680 0.037 0.014 DBMET01956 | ||
| 0.057 | 0.016 | 0.11 | Glutamate (mGluR1a) antagonist | 0.055 0.017 DBMET00255 0.11 0.005 DBMET01958 0.046 0.024 DBMET01959 | DBMET01958 | |
| 0.058 | 0.018 | 0.058 | CC chemokine 4 receptor antagonist | 0.055 0.021 DBMET00255 0.044 0.039 DBMET01958 | ||
| 0.101 | 0.06 | 0.101 | Insulin receptor antagonist | 0.101 0.06 DBMET01958 | ||
| 0.112 | 0.073 | 0.14 | Cholesterol synthesis inhibitor | 0.104 0.083 DBMET01958 0.14 0.05 DBMET00254 0.102 0.085 DBMET00680 | DBMET00254 | |
| 0.049 | 0.01 | 0.082 | Endothelial nitric-oxide synthase inhibitor | 0.082 0.005 DBMET00255 0.045 0.011 DBMET01958 0.074 0.005 DBMET01959 0.03 0.023 DBMET00314 | DBMET00255 | |
| 0.046 | 0.007 | 0.046 | Urotensin II agonist | 0.039 0.01 DBMET00254 | ||
| 0.138 | 0.099 | 0.202 | CF transmembrane conductance regulator agonist | 0.202 0.02 DBMET01958 0.129 0.121 DBMET01959 0.15 0.075 DBMET00254 | DBMET01958 | |
| 0.067 | 0.029 | 0.099 | Beta 1 adrenoreceptor antagonist | 0.082 0.017 DBMET00255 0.081 0.017 DBMET01958 0.051 0.045 DBMET01959 0.081 0.017 DBMET00254 0.099 0.01 DBMET00314 | DBMET00314 | |
| 0.1 | 0.062 | 0.135 | Anabolic | 0.135 0.027 DBMET01958 0.098 0.065 DBMET01959 0.121 0.038 DBMET00254 0.106 0.055 DBMET00314 0.112 0.047 DBMET01961 | DBMET01958 | |
| 0.054 | 0.017 | 0.06 | Dopamine D3 agonist | 0.056 0.016 DBMET00255 0.05 0.019 DBMET01958 0.06 0.014 DBMET01959 0.051 0.019 DBMET00254 0.052 0.018 DBMET00314 | DBMET01959 | |
| 0.045 | 0.009 | 0.045 | Benzodiazepine receptor peripheral-type antagonist | 0.043 0.011 DBMET01958 0.033 0.026 DBMET00254 | ||
| 0.038 | 0.003 | 0.057 | CXC chemokine 4 receptor agonist | 0.035 0.003 DBMET00255 0.022 0.005 DBMET01957 0.028 0.004 DBMET01958 0.057 0.002 DBMET01959 0.025 0.004 DBMET00254 0.023 0.005 DBMET00314 0.026 0.004 DBMET01961 | DBMET01959 | |
| 0.082 | 0.046 | 0.152 | Estrogen receptor alpha antagonist | 0.085 0.041 DBMET01958 0.152 0.011 DBMET00254 0.097 0.029 DBMET00314 | DBMET00254 | |
| 0.05 | 0.014 | 0.068 | Nociceptin (N/OFQ) receptor antagonist | 0.05 0.014 DBMET00255 0.046 0.017 DBMET01958 0.068 0.009 DBMET01959 0.034 0.025 DBMET00254 0.036 0.024 DBMET00314 0.04 0.021 DBMET01961 | DBMET01959 | |
| 0.054 | 0.019 | 0.081 | Histamine H2 receptor agonist | 0.075 0.009 DBMET00255 0.081 0.007 DBMET01958 0.059 0.015 DBMET01959 | DBMET01958 | |
| 0.04 | 0.005 | 0.05 | Estrogen-related receptor gamma antagonist | 0.029 0.017 DBMET00255 0.029 0.018 DBMET01958 0.05 0.003 DBMET00254 0.037 0.007 DBMET00314 | DBMET00254 | |
| 0.044 | 0.009 | 0.052 | CXC chemokine receptor agonist | 0.043 0.01 DBMET00255 0.035 0.023 DBMET01958 0.052 0.004 DBMET01959 | DBMET01959 | |
| 0.105 | 0.071 | 0.174 | GABA receptor agonist | 0.101 0.076 DBMET00255 0.174 0.025 DBMET01958 0.133 0.046 DBMET01959 | DBMET01958 | |
| 0.065 | 0.031 | 0.073 | Phosphodiesterase 1A inhibitor | 0.073 0.021 DBMET01958 | DBMET01958 | |
| 0.062 | 0.029 | 0.062 | Nicotinic alpha7 receptor agonist | 0.055 0.037 DBMET00255 0.056 0.035 DBMET01958 | ||
| 0.054 | 0.021 | 0.11 | Antidiuretic hormone antagonist | 0.034 0.031 DBMET00255 0.037 0.029 DBMET01958 0.08 0.016 DBMET01959 0.11 0.011 DBMET01961 | DBMET01961 | |
| 0.042 | 0.009 | 0.042 | Adenosine uptake inhibitor | 0.04 0.012 DBMET00255 0.036 0.02 DBMET01958 0.038 0.016 DBMET01959 0.033 0.03 DBMET00254 | ||
| 0.101 | 0.069 | 0.35 | Ferrochelatase inhibitor | 0.087 0.086 DBMET00255 0.35 0.005 DBMET01958 0.176 0.028 DBMET01959 0.087 0.086 DBMET01961 | DBMET01958 | |
| 0.057 | 0.026 | 0.082 | 5 Hydroxytryptamine 1A agonist | 0.082 0.019 DBMET00255 0.078 0.02 DBMET01958 0.056 0.026 DBMET01959 | DBMET00255 | |
| 0.064 | 0.034 | 0.064 | Potassium channel intermediate-conductance Ca-activated blocker | 0.064 0.034 DBMET01958 0.064 0.035 DBMET01959 | ||
| 0.105 | 0.076 | 0.122 | Nav1.5 sodium channel blocker | 0.122 0.052 DBMET00255 0.118 0.057 DBMET01958 0.118 0.057 DBMET01959 | DBMET00255 | |
| 0.048 | 0.019 | 0.109 | Dopamine D5 agonist | 0.046 0.021 DBMET00255 0.109 0.004 DBMET01958 0.1 0.004 DBMET01959 0.092 0.005 DBMET00254 0.088 0.005 DBMET00314 0.056 0.014 DBMET01961 | DBMET01958 | |
| 0.074 | 0.045 | 0.142 | Benzodiazepine agonist | 0.142 0.009 DBMET01958 | DBMET01958 | |
| 0.041 | 0.014 | 0.059 | Acetylcholine M4 receptor agonist | 0.059 0.009 DBMET01958 | DBMET01958 | |
| 0.043 | 0.017 | 0.055 | Delayed rectifier potassium channel blocker | 0.055 0.009 DBMET00255 0.037 0.026 DBMET01958 0.04 0.021 DBMET01959 0.04 0.022 DBMET00254 0.05 0.011 DBMET00314 | DBMET00255 | |
| 0.093 | 0.067 | 0.138 | Phosphodiesterase 6D inhibitor | 0.126 0.02 DBMET01958 0.096 0.059 DBMET00254 0.138 0.013 DBMET00680 0.116 0.029 DBMET01956 | DBMET00680 | |
| 0.064 | 0.039 | 0.066 | Phosphodiesterase 1C inhibitor | 0.066 0.035 DBMET01958 0.058 0.055 DBMET00254 | DBMET01958 | |
| 0.044 | 0.019 | 0.119 | 5 Hydroxytryptamine 2B agonist | 0.039 0.028 DBMET00255 0.119 0.004 DBMET01958 0.064 0.007 DBMET01959 | DBMET01958 | |
| 0.104 | 0.079 | 0.104 | Interleukin 2 antagonist | |||
| 0.034 | 0.009 | 0.034 | Myristoyl transferase inhibitor | 0.033 0.01 DBMET00255 0.033 0.01 DBMET01959 | ||
| 0.065 | 0.041 | 0.099 | 5 Hydroxytryptamine 3 agonist | 0.099 0.016 DBMET01958 0.074 0.031 DBMET01959 | DBMET01958 | |
| 0.057 | 0.033 | 0.057 | Melanin-concentrating hormone receptor 1 antagonist | |||
| 0.069 | 0.045 | 0.084 | Neuronal nicotinic receptor antagonist | 0.081 0.036 DBMET00255 0.084 0.033 DBMET01958 0.068 0.046 DBMET01959 0.059 0.055 DBMET00314 | DBMET01958 | |
| 0.088 | 0.066 | 0.126 | Alcohol dehydrogenase inhibitor | 0.087 0.069 DBMET01958 0.11 0.043 DBMET01959 0.126 0.031 DBMET00254 0.107 0.046 DBMET00314 0.096 0.057 DBMET01961 0.099 0.053 DBMET00680 0.083 0.075 DBMET01956 | DBMET00254 | |
| 0.062 | 0.041 | 0.089 | Corticotropin releasing factor 2 receptor antagonist | 0.058 0.051 DBMET00255 0.081 0.016 DBMET01958 0.089 0.011 DBMET01959 | DBMET01959 | |
| 0.053 | 0.032 | 0.09 | Beta 2 adrenoreceptor antagonist | 0.068 0.018 DBMET00255 0.07 0.017 DBMET01958 0.049 0.037 DBMET01959 0.073 0.015 DBMET00254 0.09 0.009 DBMET00314 0.051 0.035 DBMET01961 | DBMET00314 | |
| 0.062 | 0.04 | 0.095 | Cyclin D1 inhibitor | 0.055 0.051 DBMET00255 0.095 0.009 DBMET01958 0.07 0.029 DBMET01959 0.054 0.053 DBMET00254 | DBMET01958 | |
| 0.05 | 0.029 | 0.068 | Cytokine production stimulant | 0.052 0.024 DBMET00255 0.053 0.022 DBMET01958 0.068 0.008 DBMET01959 0.048 0.034 DBMET01961 0.048 0.034 DBMET00680 0.05 0.029 DBMET01956 | DBMET01959 | |
| 0.033 | 0.013 | 0.04 | 5 Hydroxytryptamine 6 agonist | 0.04 0.007 DBMET01958 0.031 0.015 DBMET01959 | DBMET01958 | |
| 0.029 | 0.008 | 0.029 | Apolipoprotein B inhibitor | 0.025 0.01 DBMET00255 | ||
| 0.066 | 0.045 | 0.109 | Beta adrenoreceptor antagonist | 0.08 0.027 DBMET00255 0.083 0.025 DBMET01958 0.088 0.022 DBMET00254 0.109 0.013 DBMET00314 0.071 0.037 DBMET01961 | DBMET00314 | |
| 0.085 | 0.065 | 0.141 | NADH dehydrogenase inhibitor | 0.135 0.022 DBMET01958 0.09 0.056 DBMET01959 0.083 0.069 DBMET00254 0.104 0.04 DBMET01961 0.141 0.02 DBMET00680 0.106 0.038 DBMET01956 | DBMET00680 | |
| 0.051 | 0.032 | 0.086 | Dopamine transporter inhibitor | 0.08 0.017 DBMET00255 0.086 0.015 DBMET01957 0.051 0.031 DBMET00314 0.042 0.041 DBMET01961 | DBMET01957 | |
| 0.035 | 0.017 | 0.035 | Vanilloid 4 antagonist | 0.034 0.019 DBMET00255 | ||
| 0.055 | 0.037 | 0.069 | Epithelial sodium channel blocker | 0.055 0.037 DBMET00255 0.069 0.019 DBMET01958 0.062 0.026 DBMET01959 | DBMET01958 | |
| 0.057 | 0.038 | 0.077 | Pregnane X receptor antagonist | 0.077 0.008 DBMET01958 | DBMET01958 | |
| 0.078 | 0.061 | 0.134 | Opioid kappa receptor antagonist | 0.095 0.04 DBMET00255 0.084 0.052 DBMET01958 0.091 0.044 DBMET01959 0.116 0.025 DBMET00254 0.134 0.02 DBMET00314 | DBMET00314 | |
| 0.054 | 0.037 | 0.081 | Toll-Like receptor 8 antagonist | 0.081 0.017 DBMET01958 0.058 0.033 DBMET01959 | DBMET01958 | |
| 0.055 | 0.037 | 0.055 | Cannabinoid CB2 receptor agonist | 0.053 0.039 DBMET00255 | ||
| 0.073 | 0.056 | 0.136 | CYP2A6 inhibitor | 0.075 0.053 DBMET00255 0.136 0.021 DBMET01958 0.113 0.03 DBMET01959 | DBMET01958 | |
| 0.04 | 0.025 | 0.054 | Histone deacetylase 9 inhibitor | 0.054 0.014 DBMET00255 0.048 0.017 DBMET01958 0.039 0.027 DBMET00314 | DBMET00255 | |
| 0.058 | 0.043 | 0.115 | Androgen agonist | 0.115 0.011 DBMET01958 0.075 0.027 DBMET00254 0.057 0.045 DBMET00314 0.065 0.035 DBMET01961 | DBMET01958 | |
| 0.021 | 0.006 | 0.028 | NMDA receptor phencyclidine site antagonist | 0.017 0.009 DBMET00255 0.023 0.005 DBMET01958 0.028 0.005 DBMET00254 0.021 0.006 DBMET00314 | DBMET00254 | |
| 0.037 | 0.022 | 0.041 | Retinoid X alpha receptor agonist | 0.031 0.029 DBMET01958 0.041 0.019 DBMET01959 | DBMET01959 | |
| 0.141 | 0.126 | 0.197 | Neurotensin receptor agonist | 0.168 0.066 DBMET00255 0.17 0.062 DBMET01958 0.197 0.036 DBMET01959 0.166 0.069 DBMET00254 0.195 0.038 DBMET00314 0.155 0.09 DBMET01961 | DBMET01959 | |
| 0.037 | 0.023 | 0.09 | ATM kinase inhibitor | 0.09 0.004 DBMET01957 | DBMET01957 | |
| 0.043 | 0.029 | 0.049 | Nerve growth factor antagonist | 0.041 0.034 DBMET00255 0.049 0.019 DBMET01958 | DBMET01958 | |
| 0.034 | 0.021 | 0.039 | Vasopressin 1 antagonist | 0.039 0.018 DBMET01959 | DBMET01959 | |
| 0.082 | 0.069 | 0.15 | Granulocyte macrophage colony stimulating factor agonist | 0.15 0.005 DBMET01958 0.09 0.051 DBMET01959 0.084 0.065 DBMET00254 | DBMET01958 | |
| 0.23 | 0.217 | 0.52 | MAP kinase kinase 6 inhibitor | 0.52 0.014 DBMET01958 | DBMET01958 | |
| 0.133 | 0.12 | 0.223 | Interleukin 6 antagonist | 0.182 0.053 DBMET01958 0.151 0.087 DBMET00254 0.152 0.086 DBMET01961 0.223 0.03 DBMET00680 0.184 0.052 DBMET01956 | DBMET00680 | |
| 0.116 | 0.104 | 0.534 | Peroxidase inhibitor | 0.534 0.007 DBMET01958 0.301 0.037 DBMET01959 0.3 0.037 DBMET00254 0.28 0.041 DBMET00314 0.144 0.081 DBMET01961 | DBMET01958 | |
| 0.06 | 0.048 | 0.081 | Histone deacetylase SIRT3 inhibitor | 0.081 0.018 DBMET00255 0.07 0.029 DBMET01958 0.081 0.018 DBMET01959 0.069 0.03 DBMET00314 | DBMET01959 | |
| 0.067 | 0.055 | 0.19 | NMDA 2 receptor antagonist | 0.1 0.032 DBMET00255 0.136 0.02 DBMET01958 0.166 0.013 DBMET01959 0.122 0.023 DBMET00254 0.171 0.013 DBMET00314 0.19 0.01 DBMET01961 | DBMET01961 | |
| 0.026 | 0.014 | 0.028 | 5 Hydroxytryptamine 4 agonist | 0.028 0.01 DBMET00255 0.027 0.01 DBMET01959 | DBMET00255 | |
| 0.053 | 0.042 | 0.068 | Nicotinic neuronal receptor agonist | 0.068 0.029 DBMET00255 0.062 0.033 DBMET01958 | DBMET00255 | |
| 0.064 | 0.052 | 0.075 | Potassium channel (ATP-sensitive) blocker | 0.075 0.033 DBMET01958 | DBMET01958 | |
| 0.1 | 0.089 | 0.154 | Beta amyloid protein antagonist | 0.105 0.083 DBMET00255 0.154 0.038 DBMET01958 0.131 0.056 DBMET01959 0.104 0.084 DBMET00680 0.109 0.078 DBMET01956 | DBMET01958 | |
| 0.038 | 0.028 | 0.101 | Alpha 1d adrenoreceptor agonist | 0.066 0.009 DBMET00255 0.101 0.004 DBMET01958 0.063 0.009 DBMET01959 0.044 0.021 DBMET00314 | DBMET01958 | |
| 0.092 | 0.082 | 0.158 | Adenylate kinase inhibitor | 0.089 0.088 DBMET00255 0.158 0.024 DBMET01958 0.112 0.051 DBMET01959 0.129 0.037 DBMET01961 | DBMET01958 | |
| 0.022 | 0.012 | 0.032 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.032 0.004 DBMET01958 | DBMET01958 | |
| 0.078 | 0.068 | 0.115 | GABA A receptor agonist | 0.075 0.073 DBMET00255 0.115 0.026 DBMET01958 | DBMET01958 | |
| 0.087 | 0.077 | 0.103 | Interleukin 1 beta converting enzyme inhibitor | 0.103 0.053 DBMET00255 0.089 0.074 DBMET01958 0.089 0.074 DBMET01959 0.099 0.059 DBMET00314 | DBMET00255 | |
| 0.027 | 0.018 | 0.036 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.036 0.007 DBMET01958 | DBMET01958 | |
| 0.041 | 0.032 | 0.064 | Guanylate cyclase inhibitor | 0.064 0.008 DBMET01957 0.057 0.014 DBMET01958 0.04 0.034 DBMET00680 | DBMET01957 | |
| 0.074 | 0.066 | 0.194 | Protein kinase A inhibitor | 0.116 0.035 DBMET00255 0.107 0.041 DBMET01958 0.194 0.014 DBMET01959 0.095 0.049 DBMET00314 0.152 0.024 DBMET01961 | DBMET01959 | |
| 0.077 | 0.069 | 0.203 | NMDA receptor antagonist | 0.105 0.044 DBMET00255 0.203 0.014 DBMET01958 0.166 0.02 DBMET01959 0.127 0.032 DBMET00254 0.171 0.019 DBMET00314 0.164 0.02 DBMET01961 | DBMET01958 | |
| 0.07 | 0.061 | 0.13 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.123 0.028 DBMET01957 0.13 0.025 DBMET01958 0.122 0.028 DBMET00254 | DBMET01958 | |
| 0.022 | 0.014 | 0.035 | Glutaminyl-peptide cyclotransferase inhibitor | 0.035 0.005 DBMET00255 0.02 0.019 DBMET01958 0.026 0.009 DBMET01959 0.021 0.016 DBMET00314 | DBMET00255 | |
| 0.042 | 0.035 | 0.042 | Oleamide hydrolase inhibitor | |||
| 0.038 | 0.032 | 0.051 | Histone deacetylase 8 inhibitor | 0.051 0.021 DBMET00255 0.049 0.022 DBMET01958 0.039 0.03 DBMET01959 0.04 0.03 DBMET00314 | DBMET00255 | |
| 0.07 | 0.064 | 0.076 | Potassium channel (Tandem pore domain) blocker | 0.076 0.046 DBMET01958 0.07 0.065 DBMET01959 | DBMET01958 | |
| 0.108 | 0.102 | 0.108 | Cytokine production inhibitor | |||
| 0.073 | 0.067 | 0.183 | Adrenaline agonist | 0.122 0.024 DBMET00255 0.117 0.027 DBMET01958 0.075 0.065 DBMET01959 0.12 0.025 DBMET00254 0.183 0.009 DBMET00314 0.075 0.064 DBMET01961 | DBMET00314 | |
| 0.185 | 0.18 | 0.185 | Nootropic | |||
| 0.038 | 0.033 | 0.054 | Liver X receptor alpha agonist | 0.054 0.016 DBMET01958 0.053 0.017 DBMET00254 | DBMET01958 | |
| 0.03 | 0.025 | 0.085 | Vasopressin 2 antagonist | 0.043 0.017 DBMET01958 0.043 0.017 DBMET01959 0.085 0.007 DBMET01961 | DBMET01961 | |
| 0.02 | 0.015 | 0.027 | Toll-Like receptor 8 agonist | 0.027 0.005 DBMET01959 | DBMET01959 | |
| 0.018 | 0.013 | 0.018 | Apolipoprotein B-100 inhibitor | |||
| 0.064 | 0.06 | 0.08 | Exportin-1 inhibitor | 0.08 0.025 DBMET01958 0.069 0.046 DBMET01959 | DBMET01958 | |
| 0.034 | 0.031 | 0.052 | Somatostatin 4 agonist | 0.037 0.026 DBMET01958 0.052 0.014 DBMET01959 | DBMET01959 | |
| 0.017 | 0.014 | 0.027 | Histamine H4 receptor agonist | 0.027 0.008 DBMET00255 0.018 0.013 DBMET01958 0.023 0.009 DBMET01959 | DBMET00255 | |
| 0.036 | 0.034 | 0.089 | AMPA 4 receptor antagonist | 0.089 0.005 DBMET01958 0.055 0.012 DBMET01959 | DBMET01958 | |
| 0.025 | 0.023 | 0.029 | Vasopressin 1A antagonist | 0.029 0.02 DBMET01958 0.027 0.021 DBMET01959 | DBMET01958 | |
| 0.037 | 0.036 | 0.056 | Thymidine kinase inhibitor | 0.056 0.015 DBMET01958 | DBMET01958 | |
| 0.069 | 0.068 | 0.086 | Vanilloid 4 agonist | 0.082 0.037 DBMET00255 0.086 0.031 DBMET01958 | DBMET01958 | |
| 0.044 | 0.044 | 0.089 | Neuropeptide Y5 antagonist | 0.089 0.019 DBMET01958 | DBMET01958 | |
| 0.038 | 0.038 | 0.144 | NMDA receptor subunit 3B antagonist | 0.041 0.033 DBMET00255 0.144 0.007 DBMET01958 0.044 0.03 DBMET01959 0.07 0.016 DBMET00254 0.079 0.014 DBMET00314 | DBMET01958 | |
| 0.022 | 0.022 | 0.052 | Methionyl aminopeptidase 2 inhibitor | 0.052 0.006 DBMET01958 | DBMET01958 | |
| 0.063 | 0.063 | 0.085 | MDM2 inhibitor | 0.085 0.015 DBMET01958 0.065 0.055 DBMET01959 | DBMET01958 | |
| 0.04 | 0.041 | 0.045 | Heme oxygenase inhibitor | 0.045 0.024 DBMET01958 0.041 0.035 DBMET01959 | DBMET01958 | |
| 0.029 | 0.03 | 0.036 | Retinoid X receptor agonist | 0.036 0.024 DBMET01959 | DBMET01959 | |
| 0.023 | 0.025 | 0.031 | Acid ceramidase inhibitor | 0.026 0.017 DBMET00255 0.031 0.008 DBMET01958 | DBMET01958 | |
| 0.029 | 0.03 | 0.034 | Liver X receptor beta agonist | 0.034 0.022 DBMET01958 0.034 0.022 DBMET00254 | DBMET00254 | |
| 0.161 | 0.162 | 0.241 | Calpain inhibitor | 0.19 0.123 DBMET00255 0.241 0.074 DBMET01958 0.19 0.123 DBMET01959 | DBMET01958 | |
| 0.091 | 0.093 | 0.111 | Factor V inhibitor | 0.109 0.052 DBMET00255 0.111 0.049 DBMET01959 0.098 0.075 DBMET00314 0.095 0.082 DBMET01961 | DBMET01959 | |
| 0.065 | 0.067 | 0.176 | Glycine receptor agonist | 0.116 0.014 DBMET01958 0.139 0.008 DBMET01959 0.176 0.005 DBMET01961 | DBMET01961 | |
| 0.07 | 0.072 | 0.11 | Acetylcholine M3 receptor agonist | 0.11 0.04 DBMET01958 | DBMET01958 | |
| 0.066 | 0.068 | 0.095 | Analgesic, opioid | 0.095 0.034 DBMET00254 0.086 0.041 DBMET00314 0.069 0.063 DBMET01961 | DBMET00254 | |
| 0.084 | 0.087 | 0.12 | Alpha 2d adrenoreceptor antagonist | 0.12 0.023 DBMET01958 | DBMET01958 | |
| 0.023 | 0.026 | 0.03 | Calcium-sensing receptor agonist | 0.03 0.013 DBMET01959 | DBMET01959 | |
| 0.03 | 0.033 | 0.053 | Melatonin receptor 1A agonist | 0.039 0.014 DBMET00255 0.053 0.007 DBMET01958 0.031 0.029 DBMET00314 | DBMET01958 | |
| 0.026 | 0.031 | 0.05 | Growth hormone releasing factor agonist | 0.039 0.019 DBMET00255 0.031 0.025 DBMET01958 0.05 0.013 DBMET01959 | DBMET01959 | |
| 0.03 | 0.035 | 0.045 | Histone deacetylase 7 inhibitor | 0.045 0.02 DBMET00255 0.042 0.022 DBMET01958 | DBMET00255 | |
| 0.016 | 0.022 | 0.022 | Estrogen-related receptor gamma agonist | 0.022 0.008 DBMET00254 0.02 0.01 DBMET00314 | DBMET00254 | |
| 0.01 | 0.017 | 0.027 | Melatonin receptor 1A antagonist | 0.027 0.004 DBMET00255 0.024 0.005 DBMET01958 0.013 0.01 DBMET00314 | DBMET00255 | |
| 0.029 | 0.035 | 0.048 | RNA-directed RNA polymerase inhibitor | 0.039 0.019 DBMET00255 0.039 0.019 DBMET01958 0.034 0.025 DBMET00254 0.048 0.014 DBMET00314 | DBMET00314 | |
| 0.009 | 0.016 | 0.02 | Melatonin 2 antagonist | 0.012 0.008 DBMET00255 0.02 0.004 DBMET01958 | DBMET01958 | |
| 0.083 | 0.089 | 0.182 | Electrolyte absorption antagonist | 0.182 0.011 DBMET01958 0.099 0.059 DBMET01959 | DBMET01958 | |
| 0.057 | 0.064 | 0.074 | Beta 2 adrenoreceptor agonist | 0.063 0.036 DBMET00255 0.061 0.045 DBMET01958 0.059 0.056 DBMET01959 0.067 0.025 DBMET00254 0.074 0.013 DBMET00314 0.065 0.033 DBMET01961 | DBMET00314 | |
| 0.034 | 0.042 | 0.056 | Neurokinin 2 agonist | 0.056 0.015 DBMET01959 0.038 0.034 DBMET01961 | DBMET01959 | |
| 0.043 | 0.05 | 0.062 | Dopamine beta hydroxylase inhibitor | 0.047 0.037 DBMET00255 0.058 0.017 DBMET01958 0.062 0.014 DBMET01959 0.045 0.044 DBMET00254 0.049 0.033 DBMET00314 | DBMET01959 | |
| 0.048 | 0.056 | 0.092 | Protein kinase C iota inhibitor | 0.052 0.05 DBMET00255 0.068 0.033 DBMET01958 0.092 0.021 DBMET01959 | DBMET01959 | |
| 0.021 | 0.029 | 0.058 | Cyclin E2 inhibitor | 0.029 0.02 DBMET00255 0.058 0.007 DBMET01958 0.03 0.019 DBMET01959 | DBMET01958 | |
| 0.028 | 0.037 | 0.031 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.031 0.03 DBMET00254 | DBMET00254 | |
| 0.029 | 0.038 | 0.034 | Retinoid X alpha receptor antagonist | 0.034 0.024 DBMET01958 | DBMET01958 | |
| 0.024 | 0.034 | 0.034 | HCV NS5B polymerase inhibitor | 0.032 0.021 DBMET01958 0.034 0.019 DBMET00254 0.033 0.02 DBMET00314 | DBMET00254 | |
| 0.051 | 0.061 | 0.077 | Heat shock protein 90 beta antagonist | 0.062 0.037 DBMET01959 0.077 0.023 DBMET00254 0.064 0.034 DBMET00314 | DBMET00254 | |
| 0.046 | 0.056 | 0.062 | Nicotinic receptor alpha7 subunit antagonist | 0.062 0.027 DBMET01958 | DBMET01958 | |
| 0.02 | 0.031 | 0.053 | AMPA 3 receptor antagonist | 0.053 0.008 DBMET01958 0.042 0.012 DBMET01959 | DBMET01958 | |
| 0.064 | 0.074 | 0.115 | GABA aminotransferase inhibitor | 0.094 0.032 DBMET01958 0.115 0.018 DBMET01959 0.07 0.062 DBMET00254 0.081 0.045 DBMET01961 | DBMET01959 | |
| 0.07 | 0.081 | 0.135 | Antineoplastic alkaloid | 0.135 0.032 DBMET01958 0.104 0.045 DBMET00254 | DBMET01958 | |
| 0.029 | 0.04 | 0.034 | Ceramide glucosyltransferase inhibitor | 0.033 0.029 DBMET00255 0.034 0.028 DBMET01961 | DBMET01961 | |
| 0.092 | 0.103 | 0.22 | TRPA1 agonist | 0.22 0.008 DBMET01958 0.111 0.07 DBMET01959 0.111 0.07 DBMET00254 0.111 0.071 DBMET00314 | DBMET01958 | |
| 0.142 | 0.153 | 0.27 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.27 0.072 DBMET01958 0.164 0.126 DBMET00254 | DBMET01958 | |
| 0.031 | 0.043 | 0.038 | Retinoid X receptor antagonist | 0.038 0.027 DBMET01958 | DBMET01958 | |
| 0.011 | 0.023 | 0.028 | Growth hormone release promoting | 0.024 0.012 DBMET00255 0.028 0.011 DBMET01959 | DBMET01959 | |
| 0.058 | 0.07 | 0.247 | Porphobilinogen synthase inhibitor | 0.247 0.008 DBMET01958 0.163 0.018 DBMET01959 0.085 0.044 DBMET01961 | DBMET01958 | |
| 0.037 | 0.05 | 0.11 | Poly(ADP-ribose) polymerase inhibitor | 0.11 0.007 DBMET01958 | DBMET01958 | |
| 0.021 | 0.033 | 0.03 | Vanilloid 2 agonist | 0.03 0.01 DBMET00680 0.03 0.01 DBMET01956 | DBMET01956 | |
| 0.096 | 0.109 | 0.196 | Estrogen antagonist | 0.118 0.059 DBMET01957 0.196 0.013 DBMET00254 0.155 0.022 DBMET00314 0.103 0.091 DBMET00680 | DBMET00254 | |
| 0.053 | 0.066 | 0.069 | Ryanodine receptor antagonist | 0.069 0.019 DBMET01958 0.06 0.039 DBMET00254 | DBMET01958 | |
| 0.029 | 0.044 | 0.044 | Toll-Like receptor 2 agonist | 0.037 0.032 DBMET01958 0.044 0.026 DBMET01959 | DBMET01959 | |
| 0.07 | 0.084 | 0.126 | Opioid antagonist | 0.083 0.065 DBMET00255 0.094 0.053 DBMET01959 0.116 0.038 DBMET00254 0.126 0.034 DBMET00314 0.088 0.059 DBMET01961 | DBMET00314 | |
| 0.07 | 0.084 | 0.123 | MAP kinase kinase 7 inhibitor | 0.073 0.068 DBMET00255 0.123 0.004 DBMET01958 0.091 0.023 DBMET01959 0.092 0.022 DBMET00254 0.096 0.017 DBMET00314 0.086 0.031 DBMET01961 | DBMET01958 | |
| 0.133 | 0.149 | 0.22 | Succinate dehydrogenase inhibitor | 0.22 0.035 DBMET01958 0.167 0.084 DBMET01959 0.143 0.126 DBMET00254 0.141 0.13 DBMET00314 | DBMET01958 | |
| 0.021 | 0.038 | 0.047 | Thrombin receptor antagonist | 0.038 0.012 DBMET00255 0.047 0.01 DBMET01959 | DBMET01959 | |
| 0.051 | 0.068 | 0.063 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.063 0.037 DBMET01958 0.059 0.046 DBMET00254 | DBMET01958 | |
| 0.043 | 0.059 | 0.063 | Myc inhibitor | 0.063 0.026 DBMET00255 0.049 0.047 DBMET00314 | DBMET00255 | |
| 0.209 | 0.226 | 0.379 | Analgesic | 0.379 0.094 DBMET00255 0.319 0.127 DBMET01957 0.32 0.127 DBMET00314 0.296 0.144 DBMET01961 | DBMET00255 | |
| 0.029 | 0.047 | 0.065 | Vascular adhesion protein 1 inhibitor | 0.051 0.015 DBMET01958 0.065 0.008 DBMET01959 | DBMET01959 | |
| 0.03 | 0.049 | 0.097 | 5 Hydroxytryptamine 2C agonist | 0.097 0.008 DBMET01958 0.052 0.027 DBMET01959 | DBMET01958 | |
| 0.045 | 0.064 | 0.07 | Cyclin-dependent kinase 6 inhibitor | 0.07 0.031 DBMET01958 | DBMET01958 | |
| 0.009 | 0.028 | 0.016 | 5-Alpha-reductase 1 inhibitor | 0.016 0.012 DBMET01958 | DBMET01958 | |
| 0.233 | 0.253 | 0.49 | 5 Hydroxytryptamine release inhibitor | 0.49 0.036 DBMET01958 0.334 0.129 DBMET01959 0.256 0.22 DBMET00254 0.249 0.23 DBMET00314 0.253 0.224 DBMET01961 0.321 0.143 DBMET00680 0.313 0.151 DBMET01956 | DBMET01958 | |
| 0.025 | 0.045 | 0.112 | NMDA receptor subunit 3A antagonist | 0.112 0.007 DBMET01958 0.046 0.022 DBMET00254 0.052 0.019 DBMET00314 | DBMET01958 | |
| 0.134 | 0.156 | 0.162 | Insulin sensitizer | 0.157 0.124 DBMET01958 0.162 0.117 DBMET01959 0.158 0.123 DBMET00254 0.153 0.129 DBMET00680 | DBMET01959 | |
| 0.086 | 0.108 | 0.118 | Multidrug resistance-associated protein 1 inhibitor | 0.096 0.086 DBMET00254 0.118 0.051 DBMET00680 0.103 0.073 DBMET01956 | DBMET00680 | |
| 0.109 | 0.132 | 0.148 | Phospholipase A2 inhibitor | 0.148 0.076 DBMET01959 0.135 0.093 DBMET00254 0.12 0.118 DBMET00314 | DBMET01959 | |
| 0.013 | 0.035 | 0.019 | Complement factor D inhibitor | 0.019 0.012 DBMET01958 0.017 0.015 DBMET01959 | DBMET01958 | |
| 0.04 | 0.062 | 0.091 | Aconitate hydratase inhibitor | 0.091 0.01 DBMET01958 0.056 0.03 DBMET01959 | DBMET01958 | |
| 0.025 | 0.048 | 0.052 | Estrogen-related receptor beta antagonist | 0.052 0.005 DBMET00254 0.038 0.013 DBMET00314 | DBMET00254 | |
| 0.022 | 0.045 | 0.038 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.038 0.017 DBMET00254 | DBMET00254 | |
| 0.042 | 0.065 | 0.064 | Lysine-specific demethylase 1A inhibitor | 0.064 0.023 DBMET01958 0.064 0.024 DBMET01959 | DBMET01959 | |
| 0.044 | 0.067 | 0.061 | Glucosylceramidase inhibitor | 0.061 0.03 DBMET01958 0.06 0.032 DBMET01961 | DBMET01958 | |
| 0.026 | 0.049 | 0.041 | CC chemokine 3 receptor antagonist | 0.041 0.029 DBMET01957 | DBMET01957 | |
| 0.02 | 0.043 | 0.051 | Sirtuin 2 inhibitor | 0.029 0.027 DBMET00255 0.051 0.012 DBMET01958 0.046 0.014 DBMET01959 | DBMET01958 | |
| 0.048 | 0.072 | 0.059 | Fibroblast growth factor 2 antagonist | 0.059 0.053 DBMET00255 | DBMET00255 | |
| 0.017 | 0.041 | 0.036 | 5 Hydroxytryptamine 1F agonist | 0.036 0.009 DBMET01958 | DBMET01958 | |
| 0.017 | 0.042 | 0.043 | Liver X receptor beta antagonist | 0.043 0.011 DBMET01958 0.025 0.024 DBMET00254 | DBMET01958 | |
| 0.025 | 0.049 | 0.043 | GHS receptor antagonist | 0.043 0.01 DBMET01958 | DBMET01958 | |
| 0.003 | 0.029 | 0.007 | Integrin alpha5beta6 antagonist | 0.007 0.004 DBMET01958 | DBMET01958 | |
| 0.057 | 0.083 | 0.067 | Secretase beta inhibitor | 0.067 0.056 DBMET01958 | DBMET01958 | |
| 0.012 | 0.038 | 0.018 | 5-Alpha-reductase 2 inhibitor | 0.018 0.015 DBMET01958 | DBMET01958 | |
| 0.11 | 0.136 | 0.19 | Cyclin-dependent kinase 8 inhibitor | 0.19 0.043 DBMET01958 | DBMET01958 | |
| 0.155 | 0.181 | 0.397 | Peptidyltransferase inhibitor | 0.278 0.034 DBMET00255 0.293 0.027 DBMET01959 0.191 0.111 DBMET00254 0.28 0.033 DBMET00314 0.316 0.019 DBMET01961 0.371 0.009 DBMET00680 0.397 0.007 DBMET01956 | DBMET01956 | |
| 0.194 | 0.22 | 0.368 | 15-Lipoxygenase inhibitor | 0.368 0.089 DBMET01958 0.325 0.115 DBMET00254 0.312 0.124 DBMET00314 | DBMET01958 | |
| 0.046 | 0.073 | 0.064 | Phosphodiesterase 1B inhibitor | 0.064 0.037 DBMET01958 | DBMET01958 | |
| 0.013 | 0.041 | 0.082 | Imidazoline I1 receptor antagonist | 0.082 0.003 DBMET01958 0.022 0.013 DBMET01959 | DBMET01958 | |
| 0.091 | 0.119 | 0.139 | Bone formation stimulant | 0.114 0.091 DBMET01959 0.139 0.068 DBMET00254 0.115 0.09 DBMET00314 0.121 0.085 DBMET00680 0.105 0.101 DBMET01956 | DBMET00254 | |
| 0.022 | 0.05 | 0.026 | Hedgehog signaling activator | 0.026 0.022 DBMET01958 | DBMET01958 | |
| 0.026 | 0.054 | 0.099 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.099 0.007 DBMET01958 | DBMET01958 | |
| 0.171 | 0.2 | 0.63 | Transcription factor NF kappa B inhibitor | 0.195 0.174 DBMET00255 0.259 0.121 DBMET01958 0.201 0.168 DBMET01959 0.275 0.11 DBMET00254 0.297 0.096 DBMET00314 0.283 0.104 DBMET01961 0.601 0.031 DBMET00680 0.63 0.028 DBMET01956 | DBMET01956 | |
| 0.124 | 0.154 | 0.255 | I kappa B kinase epsilon inhibitor | 0.177 0.092 DBMET00255 0.255 0.035 DBMET01958 0.148 0.122 DBMET00314 | DBMET01958 | |
| 0.028 | 0.058 | 0.041 | Membrane dipeptidase inhibitor | 0.041 0.025 DBMET01958 | DBMET01958 | |
| 0.017 | 0.048 | 0.051 | Arginase inhibitor | 0.043 0.019 DBMET01959 0.042 0.02 DBMET01961 0.05 0.015 DBMET00680 0.051 0.014 DBMET01956 | DBMET01956 | |
| 0.009 | 0.041 | 0.014 | Cyclin D2 inhibitor | 0.014 0.008 DBMET01958 | DBMET01958 | |
| 0.013 | 0.045 | 0.052 | Kainate receptor 4 antagonist | 0.052 0.006 DBMET01958 | DBMET01958 | |
| 0.11 | 0.142 | 0.152 | Thiol protease inhibitor | 0.152 0.067 DBMET01958 0.136 0.086 DBMET01959 | DBMET01958 | |
| 0.056 | 0.087 | 0.112 | Nicotinic alpha4beta2 receptor antagonist | 0.087 0.043 DBMET00255 0.112 0.022 DBMET01958 0.089 0.041 DBMET01959 | DBMET01958 | |
| 0.033 | 0.066 | 0.043 | Farnesyltransferase inhibitor | 0.043 0.037 DBMET01958 | DBMET01958 | |
| 0.07 | 0.103 | 0.095 | Phosphodiesterase I inhibitor | 0.095 0.051 DBMET01958 | DBMET01958 | |
| 0.047 | 0.081 | 0.075 | Immunoglobulin Fc receptor antagonist | 0.056 0.036 DBMET00255 0.075 0.008 DBMET01958 0.052 0.05 DBMET00314 | DBMET01958 | |
| 0.02 | 0.054 | 0.038 | Melatonin agonist | 0.038 0.017 DBMET00255 0.035 0.02 DBMET01958 0.033 0.022 DBMET00314 | DBMET00255 | |
| 0.103 | 0.137 | 0.144 | Vanilloid 1 agonist | 0.118 0.092 DBMET00255 0.144 0.045 DBMET01958 0.112 0.107 DBMET01959 0.114 0.104 DBMET00254 0.129 0.068 DBMET00314 0.118 0.093 DBMET01956 | DBMET01958 | |
| 0.064 | 0.098 | 0.144 | Inducible nitric-oxide synthase inhibitor | 0.105 0.033 DBMET00255 0.144 0.017 DBMET01958 0.106 0.032 DBMET01959 0.078 0.066 DBMET00314 0.108 0.031 DBMET01961 | DBMET01958 | |
| 0.019 | 0.053 | 0.025 | Antidiuretic hormone agonist | 0.025 0.024 DBMET01959 | DBMET01959 | |
| 0.018 | 0.053 | 0.08 | Kainate receptor 2 antagonist | 0.08 0.007 DBMET01958 | DBMET01958 | |
| 0.011 | 0.047 | 0.027 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.027 0.02 DBMET01958 | DBMET01958 | |
| 0.03 | 0.065 | 0.045 | GHS receptor agonist | 0.04 0.033 DBMET01958 0.045 0.026 DBMET01959 | DBMET01959 | |
| 0.087 | 0.123 | 0.31 | Alpha-N-acetylglucosaminidase inhibitor | 0.31 0.015 DBMET01958 0.136 0.064 DBMET01961 0.111 0.087 DBMET00680 0.119 0.079 DBMET01956 | DBMET01958 | |
| 0.012 | 0.048 | 0.033 | Progesterone receptor B antagonist | 0.033 0.004 DBMET01958 | DBMET01958 | |
| 0.04 | 0.076 | 0.091 | Carbamoyl phosphate synthetase inhibitor | 0.089 0.024 DBMET01958 0.073 0.032 DBMET01959 0.091 0.024 DBMET01961 | DBMET01961 | |
| 0.014 | 0.051 | 0.02 | Retinoid X beta receptor antagonist | 0.02 0.015 DBMET01958 | DBMET01958 | |
| 0.047 | 0.084 | 0.064 | Histone deacetylase inhibitor | 0.058 0.057 DBMET00255 0.064 0.048 DBMET01958 | DBMET01958 | |
| 0.044 | 0.082 | 0.072 | Purinergic P2X1 antagonist | 0.072 0.03 DBMET01958 | DBMET01958 | |
| 0.015 | 0.053 | 0.043 | Nicotinic alpha4beta2 receptor agonist | 0.029 0.018 DBMET00255 0.043 0.006 DBMET01958 | DBMET01958 | |
| 0.073 | 0.111 | 0.107 | MAP kinase kinase 1 inhibitor | 0.107 0.048 DBMET01958 | DBMET01958 | |
| 0.009 | 0.048 | 0.026 | Melatonin 1 antagonist | 0.017 0.015 DBMET00255 0.026 0.008 DBMET01958 | DBMET01958 | |
| 0.01 | 0.049 | 0.038 | Alpha 2c adrenoreceptor agonist | 0.018 0.013 DBMET00255 0.038 0.004 DBMET01958 | DBMET01958 | |
| 0.019 | 0.058 | 0.045 | 5-Alpha-reductase inhibitor | 0.045 0.021 DBMET01958 | DBMET01958 | |
| 0.076 | 0.116 | 0.122 | Carbonic anhydrase XV inhibitor | 0.122 0.045 DBMET01958 0.112 0.053 DBMET01959 0.093 0.077 DBMET00254 0.104 0.062 DBMET01961 | DBMET01958 | |
| 0.028 | 0.07 | 0.086 | AMPA receptor antagonist | 0.086 0.015 DBMET01958 | DBMET01958 | |
| 0.047 | 0.089 | 0.066 | Vanilloid antagonist | 0.066 0.061 DBMET01958 | DBMET01958 | |
| 0.078 | 0.121 | 0.108 | MAP kinase 13 inhibitor | 0.108 0.07 DBMET01958 0.098 0.085 DBMET01959 | DBMET01958 | |
| 0.017 | 0.06 | 0.028 | Integrin alpha2beta1 antagonist | 0.028 0.015 DBMET01958 | DBMET01958 | |
| 0.042 | 0.086 | 0.118 | Sphingosine 1-phosphate receptor 4 agonist | 0.118 0.017 DBMET01958 | DBMET01958 | |
| 0.005 | 0.048 | 0.025 | Imidazoline I2 receptor antagonist | 0.025 0.003 DBMET01958 | DBMET01958 | |
| 0.052 | 0.097 | 0.111 | Glutamate dehydrogenase inhibitor | 0.088 0.038 DBMET01958 0.1 0.031 DBMET01959 0.111 0.026 DBMET01961 | DBMET01961 | |
| 0.082 | 0.127 | 0.126 | MAP kinase 12 inhibitor | 0.126 0.063 DBMET01958 0.104 0.092 DBMET01959 | DBMET01958 | |
| 0.025 | 0.071 | 0.062 | Adenosine deaminase inhibitor | 0.045 0.035 DBMET01958 0.057 0.023 DBMET01959 0.062 0.019 DBMET01961 | DBMET01961 | |
| 0.049 | 0.095 | 0.088 | Aminopeptidase I inhibitor | 0.088 0.035 DBMET01958 0.079 0.043 DBMET01959 0.069 0.054 DBMET01961 | DBMET01958 | |
| 0.05 | 0.096 | 0.178 | Topoisomerase II alpha inhibitor | 0.108 0.035 DBMET00254 0.071 0.06 DBMET00314 0.178 0.018 DBMET00680 0.134 0.026 DBMET01956 | DBMET00680 | |
| 0.088 | 0.134 | 0.174 | Cathepsin H inhibitor | 0.106 0.096 DBMET00255 0.174 0.032 DBMET01958 0.13 0.064 DBMET01959 | DBMET01958 | |
| 0.016 | 0.062 | 0.052 | Nicotinic alpha3beta4 receptor agonist | 0.052 0.005 DBMET01958 | DBMET01958 | |
| 0.012 | 0.059 | 0.045 | Melatonin antagonist | 0.028 0.019 DBMET00255 0.045 0.009 DBMET01958 | DBMET01958 | |
| 0.026 | 0.072 | 0.042 | Sphingosine 1-phosphate receptor 1 agonist | 0.042 0.03 DBMET01958 | DBMET01958 | |
| 0.009 | 0.059 | 0.02 | Kainate receptor 3 antagonist | 0.02 0.009 DBMET01958 | DBMET01958 | |
| 0.141 | 0.191 | 0.178 | MAP kinase kinase 5 inhibitor | 0.178 0.066 DBMET01958 | DBMET01958 | |
| 0.055 | 0.105 | 0.182 | Androgen antagonist | 0.182 0.016 DBMET01958 0.077 0.069 DBMET00254 | DBMET01958 | |
| 0.109 | 0.16 | 0.146 | Dual specificity phosphatase inhibitor | 0.146 0.098 DBMET00254 | DBMET00254 | |
| 0.036 | 0.087 | 0.095 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.095 0.015 DBMET01958 0.057 0.037 DBMET01961 | DBMET01958 | |
| 0.072 | 0.124 | 0.128 | Chelator | 0.128 0.047 DBMET00254 0.124 0.05 DBMET00314 | DBMET00254 | |
| 0.046 | 0.098 | 0.079 | Protease 3C (Human rhinovirus) inhibitor | 0.079 0.028 DBMET01958 | DBMET01958 | |
| 0.171 | 0.223 | 0.307 | Caspase 3 stimulant | 0.267 0.099 DBMET00254 0.253 0.11 DBMET00314 0.307 0.075 DBMET01961 0.306 0.076 DBMET00680 0.293 0.082 DBMET01956 | DBMET01961 | |
| 0.007 | 0.06 | 0.048 | AMPA 1 receptor antagonist | 0.048 0.012 DBMET01958 | DBMET01958 | |
| 0.011 | 0.063 | 0.025 | Calcitonin gene-related peptide antagonist | 0.025 0.018 DBMET01958 | DBMET01958 | |
| 0.072 | 0.125 | 0.223 | Toll-Like receptor 3 antagonist | 0.223 0.005 DBMET00255 0.164 0.011 DBMET01958 0.121 0.029 DBMET01959 0.177 0.009 DBMET00314 | DBMET00255 | |
| 0.035 | 0.088 | 0.053 | Protein kinase C theta inhibitor | 0.053 0.049 DBMET01958 | DBMET01958 | |
| 0.064 | 0.118 | 0.148 | Triose-phosphate isomerase inhibitor | 0.148 0.02 DBMET01958 0.083 0.071 DBMET01959 0.089 0.061 DBMET01961 0.098 0.05 DBMET00680 0.093 0.056 DBMET01956 | DBMET01958 | |
| 0.06 | 0.114 | 0.107 | GABA B receptor agonist | 0.107 0.012 DBMET01958 0.096 0.019 DBMET01959 0.081 0.04 DBMET01961 | DBMET01958 | |
| 0.055 | 0.11 | 0.085 | Phosphodiesterase VI inhibitor | 0.085 0.034 DBMET01958 | DBMET01958 | |
| 0.1 | 0.156 | 0.15 | Sphingosine 1-phosphate receptor 2 antagonist | 0.116 0.106 DBMET00255 0.15 0.041 DBMET01958 | DBMET01958 | |
| 0.045 | 0.1 | 0.057 | Leukotriene C antagonist | 0.057 0.038 DBMET01958 | DBMET01958 | |
| 0.007 | 0.063 | 0.027 | Cyclin T1 inhibitor | 0.027 0.006 DBMET01958 | DBMET01958 | |
| 0.008 | 0.064 | 0.022 | Nicotinic alpha4 receptor agonist | 0.022 0.006 DBMET01958 | DBMET01958 | |
| 0.035 | 0.092 | 0.05 | Beta adrenoreceptor agonist | 0.045 0.032 DBMET01958 0.044 0.035 DBMET00254 0.05 0.017 DBMET00314 | DBMET00314 | |
| 0.023 | 0.08 | 0.039 | Integrin alpha2 antagonist | 0.039 0.023 DBMET01958 | DBMET01958 | |
| 0.109 | 0.166 | 0.246 | Interferon gamma antagonist | 0.162 0.064 DBMET01958 0.136 0.1 DBMET00254 0.128 0.115 DBMET00314 0.127 0.118 DBMET01961 0.246 0.029 DBMET00680 0.224 0.034 DBMET01956 | DBMET00680 | |
| 0.058 | 0.115 | 0.151 | Aminopeptidase B inhibitor | 0.126 0.049 DBMET01958 0.151 0.037 DBMET01959 0.113 0.056 DBMET01961 | DBMET01959 | |
| 0.034 | 0.092 | 0.08 | Alpha-mannosidase inhibitor | 0.055 0.033 DBMET01958 0.057 0.032 DBMET01961 0.068 0.018 DBMET00680 0.08 0.011 DBMET01956 | DBMET01956 | |
| 0.042 | 0.1 | 0.074 | Cannabinoid receptor antagonist | 0.074 0.045 DBMET01958 | DBMET01958 | |
| 0.011 | 0.07 | 0.035 | Alpha 2b adrenoreceptor agonist | 0.035 0.004 DBMET01958 | DBMET01958 | |
| 0.059 | 0.118 | 0.112 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.112 0.029 DBMET01958 0.111 0.03 DBMET01959 0.079 0.066 DBMET00254 0.083 0.059 DBMET00314 0.077 0.069 DBMET01961 | DBMET01958 | |
| 0.031 | 0.09 | 0.05 | Glutamate (mGluR group III) antagonist | 0.05 0.021 DBMET01958 0.049 0.022 DBMET01959 | DBMET01958 | |
| 0.067 | 0.127 | 0.194 | Carbonic anhydrase III inhibitor | 0.194 0.017 DBMET01958 0.087 0.079 DBMET01959 0.106 0.056 DBMET00254 0.095 0.067 DBMET01961 | DBMET01958 | |
| 0.081 | 0.141 | 0.277 | Cyclooxygenase 3 inhibitor | 0.137 0.059 DBMET01958 0.139 0.058 DBMET01959 0.105 0.096 DBMET00254 0.108 0.092 DBMET00314 0.151 0.047 DBMET01961 0.271 0.007 DBMET00680 0.277 0.007 DBMET01956 | DBMET01956 | |
| 0.014 | 0.074 | 0.094 | Progesterone antagonist | 0.094 0.009 DBMET01958 | DBMET01958 | |
| 0.023 | 0.084 | 0.032 | Protein kinase (CK2) beta inhibitor | 0.032 0.025 DBMET01958 | DBMET01958 | |
| 0.022 | 0.084 | 0.083 | Phosphorylase inhibitor | 0.063 0.023 DBMET01958 0.076 0.018 DBMET00680 0.083 0.016 DBMET01956 | DBMET01956 | |
| 0.101 | 0.163 | 0.135 | Polo-like kinase-3 inhibitor | 0.135 0.103 DBMET01958 | DBMET01958 | |
| 0.022 | 0.084 | 0.066 | Growth hormone release inhibitor | 0.041 0.03 DBMET01958 0.066 0.013 DBMET01959 0.047 0.024 DBMET01961 | DBMET01959 | |
| 0.031 | 0.094 | 0.056 | Glucose-6-phosphate isomerase inhibitor | 0.056 0.022 DBMET01958 | DBMET01958 | |
| 0.016 | 0.078 | 0.045 | Phosphoglycerate kinase inhibitor | 0.037 0.023 DBMET01959 0.045 0.016 DBMET01961 | DBMET01961 | |
| 0.017 | 0.08 | 0.036 | Purinergic P2Y15 antagonist | 0.03 0.018 DBMET01958 0.03 0.017 DBMET01959 0.036 0.01 DBMET01961 | DBMET01961 | |
| 0.03 | 0.093 | 0.129 | Alcohol oxidase inhibitor | 0.129 0.013 DBMET01958 0.092 0.02 DBMET01959 0.12 0.014 DBMET01961 | DBMET01958 | |
| 0.106 | 0.169 | 0.142 | Amyloid beta precursor protein antagonist | 0.142 0.111 DBMET00254 | DBMET00254 | |
| 0.026 | 0.089 | 0.044 | Nicotinic receptor alpha3 subunit antagonist | 0.043 0.032 DBMET01958 0.044 0.03 DBMET01959 | DBMET01959 | |
| 0.061 | 0.125 | 0.11 | Pim-3 kinase inhibitor | 0.11 0.037 DBMET01958 | DBMET01958 | |
| 0.03 | 0.095 | 0.068 | Purinergic P2X4 antagonist | 0.068 0.01 DBMET01958 | DBMET01958 | |
| 0.025 | 0.089 | 0.04 | Sphingosine 1-phosphate receptor agonist | 0.04 0.037 DBMET01958 | DBMET01958 | |
| 0.029 | 0.093 | 0.037 | Leukotriene C4 antagonist | 0.037 0.035 DBMET01958 | DBMET01958 | |
| 0.014 | 0.078 | 0.028 | Lysophosphatidic acid receptor 1 agonist | 0.028 0.013 DBMET01958 | DBMET01958 | |
| 0.018 | 0.083 | 0.034 | Melatonin 1 agonist | 0.032 0.025 DBMET00255 0.034 0.021 DBMET01958 | DBMET01958 | |
| 0.027 | 0.093 | 0.1 | Glutamate (mGluR1) antagonist | 0.1 0.016 DBMET01958 | DBMET01958 | |
| 0.018 | 0.084 | 0.055 | Estradiol 17 beta-dehydrogenase inhibitor | 0.055 0.022 DBMET00254 | DBMET00254 | |
| 0.035 | 0.102 | 0.11 | Toll-Like receptor 7 antagonist | 0.087 0.031 DBMET00255 0.11 0.016 DBMET01958 | DBMET01958 | |
| 0.168 | 0.235 | 0.415 | Apoptosis antagonist | 0.227 0.15 DBMET01959 0.24 0.137 DBMET00254 0.229 0.148 DBMET00314 0.36 0.051 DBMET01961 0.415 0.034 DBMET00680 0.4 0.038 DBMET01956 | DBMET00680 | |
| 0.016 | 0.084 | 0.04 | Melatonin 2 agonist | 0.033 0.022 DBMET00255 0.04 0.015 DBMET01958 0.035 0.021 DBMET00314 | DBMET01958 | |
| 0.156 | 0.225 | 0.452 | Immunomodulator | 0.247 0.117 DBMET01959 0.452 0.031 DBMET01961 0.411 0.041 DBMET00680 0.358 0.057 DBMET01956 | DBMET01961 | |
| 0.023 | 0.092 | 0.059 | Thymidylate synthase inhibitor | 0.059 0.018 DBMET01958 | DBMET01958 | |
| 0.028 | 0.098 | 0.048 | Kainate receptor agonist | 0.048 0.016 DBMET01958 | DBMET01958 | |
| 0.008 | 0.078 | 0.031 | Kainate receptor 5 antagonist | 0.031 0.009 DBMET01958 | DBMET01958 | |
| 0.015 | 0.085 | 0.032 | Fumarate hydratase inhibitor | 0.032 0.027 DBMET01958 | DBMET01958 | |
| 0.087 | 0.158 | 0.142 | Interleukin 1 antagonist | 0.142 0.063 DBMET01958 | DBMET01958 | |
| 0.055 | 0.126 | 0.138 | Cell adhesion molecule inhibitor | 0.138 0.018 DBMET00680 0.13 0.02 DBMET01956 | DBMET00680 | |
| 0.144 | 0.215 | 0.296 | RNA-directed DNA polymerase inhibitor | 0.296 0.032 DBMET01958 | DBMET01958 | |
| 0.062 | 0.134 | 0.185 | UDP-glucose 4-epimerase inhibitor | 0.185 0.02 DBMET01958 0.088 0.077 DBMET01961 0.126 0.04 DBMET00680 0.111 0.05 DBMET01956 | DBMET01958 | |
| 0.094 | 0.165 | 0.178 | Mannose-6-phosphate isomerase inhibitor | 0.178 0.044 DBMET01958 | DBMET01958 | |
| 0.019 | 0.09 | 0.029 | Glucosylceramidase stimulant | 0.029 0.015 DBMET01958 | DBMET01958 | |
| 0.008 | 0.08 | 0.016 | CDK2/cyclin A3 inhibitor | 0.016 0.012 DBMET01958 | DBMET01958 | |
| 0.056 | 0.128 | 0.122 | Urease inhibitor | 0.122 0.043 DBMET01958 | DBMET01958 | |
| 0.062 | 0.135 | 0.101 | Protein kinase (CK2) alpha inhibitor | 0.101 0.075 DBMET01958 | DBMET01958 | |
| 0.031 | 0.104 | 0.099 | Biliverdin reductase inhibitor | 0.099 0.019 DBMET01958 0.056 0.045 DBMET01959 0.058 0.042 DBMET01961 | DBMET01958 | |
| 0.075 | 0.149 | 0.161 | DOPA decarboxylase inhibitor | 0.161 0.016 DBMET01958 0.105 0.067 DBMET01959 0.111 0.056 DBMET00254 0.099 0.077 DBMET00314 | DBMET01958 | |
| 0.112 | 0.186 | 0.182 | MAP kinase kinase 4 inhibitor | 0.182 0.023 DBMET01958 0.133 0.105 DBMET01959 0.149 0.064 DBMET00254 0.148 0.066 DBMET00314 | DBMET01958 | |
| 0.095 | 0.169 | 0.225 | Hexokinase inhibitor | 0.166 0.061 DBMET01958 0.225 0.024 DBMET00680 0.189 0.042 DBMET01956 | DBMET00680 | |
| 0.01 | 0.085 | 0.019 | Antibiotic Anthracycline-like | 0.019 0.013 DBMET00680 0.018 0.017 DBMET01956 | DBMET00680 | |
| 0.107 | 0.181 | 0.155 | MAP kinase 3 inhibitor | 0.155 0.06 DBMET01958 | DBMET01958 | |
| 0.038 | 0.113 | 0.054 | Sphingosine 1-phosphate receptor 1 antagonist | 0.054 0.044 DBMET01958 | DBMET01958 | |
| 0.006 | 0.081 | 0.042 | Alpha 2a adrenoreceptor agonist | 0.042 0.004 DBMET01958 | DBMET01958 | |
| 0.073 | 0.148 | 0.116 | Caspase 3 inhibitor | 0.116 0.065 DBMET01958 | DBMET01958 | |
| 0.078 | 0.154 | 0.154 | Toll-Like receptor 2 antagonist | 0.153 0.05 DBMET01958 0.154 0.05 DBMET01959 0.127 0.071 DBMET00254 0.149 0.053 DBMET00314 0.13 0.068 DBMET01961 | DBMET01959 | |
| 0.006 | 0.082 | 0.016 | Thromboxane A2 agonist | 0.016 0.009 DBMET01958 | DBMET01958 | |
| 0.032 | 0.108 | 0.053 | Bombesin 2 receptor antagonist | 0.053 0.029 DBMET01958 | DBMET01958 | |
| 0.064 | 0.14 | 0.139 | Cystathionine beta-synthase inhibitor | 0.139 0.046 DBMET01958 0.13 0.051 DBMET00254 0.099 0.078 DBMET00314 0.102 0.074 DBMET00680 | DBMET01958 | |
| 0.122 | 0.199 | 0.19 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.19 0.083 DBMET01958 | DBMET01958 | |
| 0.041 | 0.118 | 0.112 | Glutamate decarboxylase inhibitor | 0.112 0.024 DBMET01958 0.108 0.025 DBMET01959 0.084 0.04 DBMET01961 | DBMET01958 | |
| 0.02 | 0.097 | 0.034 | Carboxypeptidase B inhibitor | 0.034 0.021 DBMET01959 | DBMET01959 | |
| 0.011 | 0.088 | 0.045 | Cholecystokinin antagonist | 0.045 0.027 DBMET01958 | DBMET01958 | |
| 0.098 | 0.176 | 0.192 | LIM domain kinase 1 inhibitor | 0.192 0.067 DBMET01958 | DBMET01958 | |
| 0.056 | 0.134 | 0.089 | MAP kinase kinase kinase inhibitor | 0.089 0.077 DBMET01958 | DBMET01958 | |
| 0.096 | 0.175 | 0.297 | NOS3 expression enhancer | 0.245 0.028 DBMET01958 0.161 0.063 DBMET00254 0.14 0.084 DBMET00314 0.123 0.11 DBMET01961 0.297 0.018 DBMET00680 0.27 0.023 DBMET01956 | DBMET00680 | |
| 0.032 | 0.111 | 0.08 | Opioid mu receptor antagonist | 0.075 0.043 DBMET00254 0.08 0.04 DBMET00314 | DBMET00314 | |
| 0.007 | 0.086 | 0.025 | Nicotinic acid receptor 1 antagonist | 0.025 0.005 DBMET01958 | DBMET01958 | |
| 0.103 | 0.183 | 0.271 | MAP kinase kinase 2 inhibitor | 0.271 0.045 DBMET01958 | DBMET01958 | |
| 0.026 | 0.106 | 0.075 | Opioid delta receptor antagonist | 0.069 0.041 DBMET00254 0.075 0.038 DBMET00314 | DBMET00314 | |
| 0.004 | 0.085 | 0.03 | Kainate receptor 1 antagonist | 0.03 0.01 DBMET01958 | DBMET01958 | |
| 0.017 | 0.098 | 0.034 | Melanocortin 1 antagonist | 0.034 0.03 DBMET01958 | DBMET01958 | |
| 0.071 | 0.152 | 0.141 | Microtubule formation inhibitor | 0.141 0.043 DBMET01958 0.101 0.09 DBMET00680 0.101 0.089 DBMET01956 | DBMET01958 | |
| 0.03 | 0.111 | 0.054 | Leukotriene B4 antagonist | 0.054 0.036 DBMET00680 | DBMET00680 | |
| 0.002 | 0.084 | 0.011 | DNA topoisomerase III inhibitor | 0.011 0.004 DBMET01958 | DBMET01958 | |
| 0.048 | 0.13 | 0.089 | Glutamate (mGluR6) antagonist | 0.089 0.016 DBMET01958 0.068 0.044 DBMET01959 | DBMET01958 | |
| 0.034 | 0.116 | 0.066 | Cannabinoid CB1 receptor antagonist | 0.066 0.039 DBMET01958 | DBMET01958 | |
| 0.031 | 0.114 | 0.093 | Phosphofructokinase-1 inhibitor | 0.093 0.034 DBMET01958 0.064 0.052 DBMET01961 0.07 0.048 DBMET00680 0.066 0.051 DBMET01956 | DBMET01958 | |
| 0.014 | 0.098 | 0.028 | Glutamate (mGluR1) agonist | 0.028 0.012 DBMET01958 | DBMET01958 | |
| 0.103 | 0.187 | 0.2 | Tumour necrosis factor antagonist | 0.2 0.053 DBMET01958 | DBMET01958 | |
| 0.021 | 0.105 | 0.071 | Mannosidase inhibitor | 0.044 0.033 DBMET01958 0.05 0.026 DBMET01961 0.058 0.018 DBMET00680 0.071 0.011 DBMET01956 | DBMET01956 | |
| 0.026 | 0.11 | 0.05 | Vanilloid 3 antagonist | 0.05 0.009 DBMET01958 | DBMET01958 | |
| 0.049 | 0.134 | 0.181 | Carbonic anhydrase VI inhibitor | 0.181 0.015 DBMET01958 0.08 0.057 DBMET01959 0.079 0.058 DBMET01961 | DBMET01958 | |
| 0.038 | 0.125 | 0.081 | I kappa B kinase 2 inhibitor | 0.081 0.021 DBMET01958 | DBMET01958 | |
| 0.035 | 0.122 | 0.131 | Phenylalanine 4-hydroxylase inhibitor | 0.131 0.015 DBMET01958 0.08 0.037 DBMET01959 0.075 0.041 DBMET00314 0.071 0.045 DBMET01961 | DBMET01958 | |
| 0.083 | 0.17 | 0.27 | Protein kinase stimulant | 0.153 0.066 DBMET01958 0.145 0.072 DBMET01959 0.14 0.075 DBMET00314 0.241 0.029 DBMET01961 0.215 0.037 DBMET00680 0.27 0.022 DBMET01956 | DBMET01956 | |
| 0.033 | 0.121 | 0.05 | Phosphodiesterase 6C inhibitor | 0.05 0.021 DBMET01958 | DBMET01958 | |
| 0.01 | 0.098 | 0.024 | Lysine carboxypeptidase inhibitor | 0.024 0.022 DBMET01959 | DBMET01959 | |
| 0.017 | 0.106 | 0.032 | Toll-Like receptor 4 agonist | 0.026 0.019 DBMET01958 0.032 0.009 DBMET00680 0.032 0.009 DBMET01956 | DBMET01956 | |
| 0.035 | 0.124 | 0.245 | Check point kinase 1 inhibitor | 0.245 0.006 DBMET01957 0.105 0.026 DBMET01958 | DBMET01957 | |
| 0.067 | 0.156 | 0.148 | Nav1.4 sodium channel blocker | 0.148 0.035 DBMET01959 0.117 0.055 DBMET01961 | DBMET01959 | |
| 0.021 | 0.111 | 0.04 | Tryptophan 5 hydroxylase inhibitor | 0.04 0.015 DBMET01958 | DBMET01958 | |
| 0.009 | 0.1 | 0.029 | AMPA 2 receptor antagonist | 0.029 0.021 DBMET01958 | DBMET01958 | |
| 0.057 | 0.149 | 0.19 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.19 0.017 DBMET01958 0.083 0.076 DBMET01959 0.081 0.079 DBMET01961 | DBMET01958 | |
| 0.053 | 0.145 | 0.071 | Sphingosine 1-phosphate receptor antagonist | 0.071 0.069 DBMET01958 | DBMET01958 | |
| 0.028 | 0.12 | 0.049 | Baculoviral IAP repeat-containing protein inhibitor | 0.049 0.023 DBMET00255 | DBMET00255 | |
| 0.013 | 0.106 | 0.098 | Estrogen agonist | 0.098 0.018 DBMET00254 0.068 0.027 DBMET00314 0.055 0.033 DBMET00680 | DBMET00254 | |
| 0.036 | 0.13 | 0.117 | NMDA receptor agonist | 0.117 0.014 DBMET01958 0.06 0.047 DBMET01959 | DBMET01958 | |
| 0.026 | 0.12 | 0.103 | GABA B receptor antagonist | 0.103 0.005 DBMET01958 0.059 0.013 DBMET01959 | DBMET01958 | |
| 0.031 | 0.126 | 0.071 | Cyclin-dependent kinase 4 inhibitor | 0.071 0.041 DBMET01958 | DBMET01958 | |
| 0.025 | 0.121 | 0.108 | Argininosuccinate synthase inhibitor | 0.108 0.017 DBMET01958 0.055 0.041 DBMET01961 | DBMET01958 | |
| 0.018 | 0.114 | 0.06 | Carbonic anhydrase VB inhibitor | 0.06 0.035 DBMET01958 | DBMET01958 | |
| 0.063 | 0.16 | 0.132 | Histone deacetylase class III inhibitor | 0.119 0.07 DBMET00255 0.132 0.059 DBMET01959 0.111 0.078 DBMET00314 | DBMET01959 | |
| 0.061 | 0.159 | 0.162 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.162 0.055 DBMET01958 0.103 0.098 DBMET00254 | DBMET01958 | |
| 0.014 | 0.112 | 0.031 | Carnitine palmitoyltransferase 1 inhibitor | 0.031 0.03 DBMET01958 | DBMET01958 | |
| 0.028 | 0.127 | 0.055 | Alpha 1L adrenoreceptor agonist | 0.055 0.011 DBMET01958 | DBMET01958 | |
| 0.002 | 0.101 | 0.019 | Progesterone receptor A antagonist | 0.019 0.004 DBMET01958 | DBMET01958 | |
| 0.007 | 0.107 | 0.031 | Squalene synthetase inhibitor | 0.031 0.023 DBMET00680 | DBMET00680 | |
| 0.028 | 0.13 | 0.169 | NMDA 2B receptor antagonist | 0.064 0.028 DBMET01958 0.059 0.032 DBMET01959 0.048 0.047 DBMET00254 0.169 0.008 DBMET01961 | DBMET01961 | |
| 0.031 | 0.132 | 0.058 | Sphingosine kinase 2 inhibitor | 0.057 0.035 DBMET01958 0.054 0.041 DBMET01959 0.058 0.034 DBMET01961 | DBMET01961 | |
| 0.059 | 0.162 | 0.108 | Bile acid receptor antagonist | 0.108 0.035 DBMET01958 | DBMET01958 | |
| 0.031 | 0.135 | 0.059 | Fatty acid synthase inhibitor | 0.059 0.036 DBMET01958 | DBMET01958 | |
| 0.022 | 0.126 | 0.043 | Glutamate (mGluR8) agonist | 0.043 0.018 DBMET01958 | DBMET01958 | |
| 0.008 | 0.113 | 0.025 | Glutamate (mGluR1a) agonist | 0.025 0.012 DBMET01958 | DBMET01958 | |
| 0.09 | 0.195 | 0.372 | Growth hormone agonist | 0.137 0.099 DBMET00255 0.246 0.044 DBMET01958 0.372 0.02 DBMET01959 0.154 0.084 DBMET00314 0.329 0.027 DBMET01961 | DBMET01959 | |
| 0.011 | 0.117 | 0.06 | Kainate receptor antagonist | 0.06 0.016 DBMET01958 | DBMET01958 | |
| 0.004 | 0.11 | 0.055 | Estrogen receptor alpha agonist | 0.055 0.016 DBMET00254 0.035 0.023 DBMET00314 | DBMET00254 | |
| 0.027 | 0.135 | 0.073 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.073 0.019 DBMET01958 0.05 0.044 DBMET00254 | DBMET01958 | |
| 0.017 | 0.126 | 0.064 | Ornithine carbamoyltransferase inhibitor | 0.047 0.042 DBMET01958 0.061 0.031 DBMET01959 0.064 0.029 DBMET01961 | DBMET01961 | |
| 0.012 | 0.121 | 0.028 | Liver X receptor alpha antagonist | 0.028 0.022 DBMET01958 | DBMET01958 | |
| 0.025 | 0.135 | 0.044 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.044 0.023 DBMET01958 | DBMET01958 | |
| 0.025 | 0.136 | 0.057 | Pim-2 kinase inhibitor | 0.057 0.034 DBMET01958 | DBMET01958 | |
| 0.019 | 0.131 | 0.034 | ATR kinase inhibitor | 0.034 0.02 DBMET01958 | DBMET01958 | |
| 0.029 | 0.14 | 0.066 | Carbonic anhydrase stimulant | 0.064 0.036 DBMET00255 0.066 0.034 DBMET01958 0.062 0.039 DBMET01959 | DBMET01958 | |
| 0.014 | 0.126 | 0.04 | Dihydropteroate synthase inhibitor | 0.04 0.027 DBMET01958 | DBMET01958 | |
| 0.017 | 0.129 | 0.034 | Glutamate (mGluR3) antagonist | 0.034 0.03 DBMET01958 | DBMET01958 | |
| 0.043 | 0.156 | 0.07 | Adenosine A3 receptor antagonist | 0.07 0.058 DBMET01958 | DBMET01958 | |
| 0.028 | 0.142 | 0.097 | CDC7 inhibitor | 0.097 0.025 DBMET01958 | DBMET01958 | |
| 0.022 | 0.138 | 0.048 | Lysophosphatidic acid 3 receptor antagonist | 0.048 0.038 DBMET01958 | DBMET01958 | |
| 0.084 | 0.201 | 0.369 | Aryl hydrocarbon receptor agonist | 0.369 0.044 DBMET01958 | DBMET01958 | |
| 0.042 | 0.159 | 0.108 | I kappa B kinase inhibitor | 0.108 0.033 DBMET01958 | DBMET01958 | |
| 0.106 | 0.224 | 0.386 | Tumour necrosis factor alpha release inhibitor | 0.386 0.029 DBMET00680 0.373 0.032 DBMET01956 | DBMET00680 | |
| 0.041 | 0.158 | 0.094 | Protein kinase (CK2) inhibitor | 0.094 0.069 DBMET01958 | DBMET01958 | |
| 0.01 | 0.128 | 0.03 | Free fatty acid receptor 1 antagonist | 0.03 0.029 DBMET01958 | DBMET01958 | |
| 0.022 | 0.14 | 0.04 | AICAR transformylase inhibitor | 0.04 0.039 DBMET01958 | DBMET01958 | |
| 0.013 | 0.131 | 0.032 | Epoxide hydrolase 1 inhibitor | 0.032 0.019 DBMET01958 | DBMET01958 | |
| 0.017 | 0.136 | 0.085 | Aromatase inhibitor | 0.085 0.025 DBMET01958 | DBMET01958 | |
| 0.008 | 0.128 | 0.025 | Dopamine D1 agonist | 0.024 0.014 DBMET00680 0.025 0.013 DBMET01956 | DBMET01956 | |
| 0.05 | 0.171 | 0.092 | Falcipain inhibitor | 0.092 0.061 DBMET01958 0.087 0.065 DBMET00680 | DBMET01958 | |
| 0.056 | 0.178 | 0.103 | mTOR complex 2 inhibitor | 0.103 0.03 DBMET01958 | DBMET01958 | |
| 0.188 | 0.311 | 0.252 | MAP kinase 1 inhibitor | 0.252 0.231 DBMET01958 | DBMET01958 | |
| 0.007 | 0.131 | 0.051 | Somatostatin 2 antagonist | 0.051 0.015 DBMET01959 | DBMET01959 | |
| 0.014 | 0.138 | 0.027 | Thymidine phosphorylase inhibitor | 0.027 0.017 DBMET01958 | DBMET01958 | |
| 0.012 | 0.137 | 0.046 | Lysophosphatidic acid 2 receptor antagonist | 0.046 0.01 DBMET01958 | DBMET01958 | |
| 0.091 | 0.216 | 0.184 | Antimitotic | 0.143 0.128 DBMET01957 0.184 0.093 DBMET01958 | DBMET01958 | |
| 0.068 | 0.194 | 0.162 | Activin receptor-like kinase 2 inhibitor | 0.162 0.058 DBMET01958 | DBMET01958 | |
| 0.003 | 0.129 | 0.015 | Carbonic anhydrase XI inhibitor | 0.015 0.007 DBMET01958 | DBMET01958 | |
| 0.048 | 0.174 | 0.091 | Falcipain 2 inhibitor | 0.091 0.059 DBMET01958 0.084 0.065 DBMET00680 | DBMET01958 | |
| 0.025 | 0.151 | 0.052 | Glutamate (mGluR4) antagonist | 0.052 0.019 DBMET01958 0.041 0.034 DBMET01959 | DBMET01958 | |
| 0.086 | 0.213 | 0.257 | Insulin secretagoues | 0.149 0.076 DBMET01958 0.14 0.086 DBMET01959 0.124 0.105 DBMET00314 0.24 0.022 DBMET00680 0.257 0.018 DBMET01956 | DBMET01956 | |
| 0.01 | 0.137 | 0.033 | Potassium channel small-conductance Ca-activated activator | 0.033 0.02 DBMET01958 | DBMET01958 | |
| 0.029 | 0.157 | 0.06 | Botulinum neurotoxin type A inhibitor | 0.06 0.038 DBMET01958 | DBMET01958 | |
| 0.047 | 0.176 | 0.172 | HIV-1 integrase (Overall Integration) inhibitor | 0.172 0.018 DBMET01958 0.084 0.072 DBMET01959 | DBMET01958 | |
| 0.022 | 0.152 | 0.089 | GABA A receptor antagonist | 0.089 0.019 DBMET01958 | DBMET01958 | |
| 0.115 | 0.245 | 0.202 | Histone acetyltransferase inhibitor | 0.202 0.066 DBMET01958 | DBMET01958 | |
| 0.03 | 0.159 | 0.243 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.243 0.01 DBMET01957 0.114 0.029 DBMET01958 | DBMET01957 | |
| 0.057 | 0.189 | 0.117 | D-Ala-D-Ala ligase inhibitor | 0.117 0.015 DBMET01958 0.078 0.074 DBMET00314 | DBMET01958 | |
| 0.025 | 0.157 | 0.068 | Aldosterone antagonist | 0.068 0.015 DBMET01958 | DBMET01958 | |
| 0.054 | 0.186 | 0.145 | Estrogen receptor beta antagonist | 0.145 0.017 DBMET00254 0.127 0.025 DBMET00314 | DBMET00254 | |
| 0.077 | 0.21 | 0.133 | Sphingosine 1-phosphate receptor 4 antagonist | 0.133 0.051 DBMET01958 | DBMET01958 | |
| 0.021 | 0.156 | 0.09 | GABA receptor antagonist | 0.09 0.018 DBMET01958 | DBMET01958 | |
| 0.076 | 0.212 | 0.235 | Cell wall synthesis inhibitor | 0.122 0.096 DBMET01958 0.215 0.025 DBMET00680 0.235 0.019 DBMET01956 | DBMET01956 | |
| 0.095 | 0.232 | 0.292 | Platelet antagonist | 0.167 0.128 DBMET01959 0.261 0.068 DBMET01961 0.292 0.055 DBMET00680 0.285 0.058 DBMET01956 | DBMET00680 | |
| 0.029 | 0.167 | 0.069 | Carbonic anhydrase XIII inhibitor | 0.069 0.059 DBMET01958 | DBMET01958 | |
| 0.056 | 0.194 | 0.114 | MAP kinase kinase inhibitor | 0.114 0.08 DBMET01958 | DBMET01958 | |
| 0.028 | 0.166 | 0.155 | Histidine decarboxylase inhibitor | 0.104 0.03 DBMET01958 0.101 0.031 DBMET01959 0.155 0.019 DBMET01961 | DBMET01961 | |
| 0.02 | 0.159 | 0.122 | NMDA receptor glycine site agonist | 0.122 0.008 DBMET01958 | DBMET01958 | |
| 0.037 | 0.178 | 0.077 | Macrophage migration inhibitory factor inhibitor | 0.073 0.062 DBMET01958 0.077 0.056 DBMET00254 0.07 0.066 DBMET00314 | DBMET00254 | |
| 0.011 | 0.154 | 0.037 | Somatostatin agonist | 0.037 0.018 DBMET01959 | DBMET01959 | |
| 0.014 | 0.158 | 0.026 | Complement factor 1s inhibitor | 0.026 0.016 DBMET01958 | DBMET01958 | |
| 0.025 | 0.17 | 0.066 | Carbonic anhydrase VA inhibitor | 0.066 0.051 DBMET01958 | DBMET01958 | |
| 0.007 | 0.152 | 0.044 | Sodium/glucose cotransporter 2 inhibitor | 0.044 0.008 DBMET00680 0.034 0.01 DBMET01956 | DBMET00680 | |
| 0.01 | 0.155 | 0.045 | Protein 30S ribosomal subunit inhibitor | 0.045 0.009 DBMET00680 0.039 0.01 DBMET01956 | DBMET00680 | |
| 0.06 | 0.207 | 0.102 | Activin receptor-like kinase 4 inhibitor | 0.102 0.082 DBMET01958 | DBMET01958 | |
| 0.014 | 0.162 | 0.033 | Delayed rectifier potassium channel activator | 0.033 0.03 DBMET01958 | DBMET01958 | |
| 0.014 | 0.162 | 0.033 | Potassium channel KCNQ activator | 0.033 0.03 DBMET01958 | DBMET01958 | |
| 0.009 | 0.157 | 0.025 | Somatostatin 4 antagonist | 0.025 0.015 DBMET01959 | DBMET01959 | |
| 0.047 | 0.197 | 0.163 | Glycogen synthase kinase-3 alpha inhibitor | 0.163 0.057 DBMET01958 | DBMET01958 | |
| 0.009 | 0.159 | 0.037 | Nicotinic acid receptor 2 antagonist | 0.037 0.007 DBMET01958 | DBMET01958 | |
| 0.053 | 0.203 | 0.184 | Beta glucuronidase inhibitor | 0.123 0.043 DBMET01958 0.184 0.015 DBMET00680 0.159 0.021 DBMET01956 | DBMET00680 | |
| 0.018 | 0.168 | 0.041 | Dihydrofolate reductase inhibitor | 0.041 0.037 DBMET01958 | DBMET01958 | |
| 0.033 | 0.184 | 0.253 | MAP-kinase-activated kinase 2 inhibitor | 0.253 0.004 DBMET01958 | DBMET01958 | |
| 0.076 | 0.227 | 0.119 | Heat shock protein 90 antagonist | 0.119 0.116 DBMET00254 | DBMET00254 | |
| 0.065 | 0.218 | 0.232 | Cell adhesion inhibitor | 0.232 0.018 DBMET00680 0.222 0.019 DBMET01956 | DBMET00680 | |
| 0.028 | 0.18 | 0.06 | Sphingosine kinase inhibitor | 0.06 0.039 DBMET01958 | DBMET01958 | |
| 0.154 | 0.309 | 0.212 | MAP kinase kinase 3 inhibitor | 0.212 0.09 DBMET01958 0.207 0.104 DBMET01959 | DBMET01958 | |
| 0.015 | 0.171 | 0.042 | Glutamate (mGluR5) agonist | 0.042 0.039 DBMET01958 | DBMET01958 | |
| 0.02 | 0.177 | 0.056 | Glutamate (mGluR group III) agonist | 0.056 0.02 DBMET01958 | DBMET01958 | |
| 0.091 | 0.249 | 0.239 | 3C-like protease (Human coronavirus) inhibitor | 0.239 0.032 DBMET01958 | DBMET01958 | |
| 0.024 | 0.182 | 0.085 | Catalase inhibitor | 0.085 0.044 DBMET01958 | DBMET01958 | |
| 0.066 | 0.224 | 0.168 | Histone deacetylase SIRT1 inhibitor | 0.155 0.057 DBMET00255 0.149 0.062 DBMET01958 0.168 0.048 DBMET01959 0.149 0.062 DBMET00314 | DBMET01959 | |
| 0.019 | 0.179 | 0.048 | Phenylethanolamine N methyltransferase inhibitor | 0.048 0.016 DBMET01958 | DBMET01958 | |
| 0.004 | 0.166 | 0.02 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.02 0.013 DBMET01958 | DBMET01958 | |
| 0.009 | 0.172 | 0.039 | Sodium/glucose cotransporter inhibitor | 0.039 0.007 DBMET00680 0.035 0.008 DBMET01956 | DBMET00680 | |
| 0.052 | 0.216 | 0.096 | Mucolytic | 0.096 0.083 DBMET01958 | DBMET01958 | |
| 0.038 | 0.203 | 0.276 | MAP-kinase-activated kinase inhibitor | 0.276 0.004 DBMET01958 | DBMET01958 | |
| 0.005 | 0.171 | 0.05 | NMDA receptor glycine site antagonist | 0.05 0.006 DBMET01958 | DBMET01958 | |
| 0.021 | 0.188 | 0.058 | Carbonic anhydrase V inhibitor | 0.058 0.057 DBMET01958 | DBMET01958 | |
| 0.061 | 0.23 | 0.12 | Antibacterial (Helicobacter pylori) | 0.12 0.081 DBMET01958 | DBMET01958 | |
| 0.003 | 0.171 | 0.014 | Thrombopoietin agonist | 0.014 0.006 DBMET01958 | DBMET01958 | |
| 0.088 | 0.258 | 0.189 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.189 0.025 DBMET01958 | DBMET01958 | |
| 0.034 | 0.204 | 0.085 | Ornithine decarboxylase inhibitor | 0.081 0.066 DBMET01958 0.085 0.062 DBMET01959 | DBMET01959 | |
| 0.04 | 0.21 | 0.063 | Transcription factor RelA inhibitor | 0.063 0.047 DBMET01958 | DBMET01958 | |
| 0.012 | 0.183 | 0.043 | Glutamate (mGluR group I) agonist | 0.043 0.039 DBMET01958 | DBMET01958 | |
| 0.127 | 0.3 | 0.265 | Nitric-oxide synthase stimulant | 0.265 0.024 DBMET01958 | DBMET01958 | |
| 0.008 | 0.181 | 0.039 | Farnesoid X receptor agonist | 0.039 0.024 DBMET01958 | DBMET01958 | |
| 0.011 | 0.185 | 0.082 | Cyclin E1 inhibitor | 0.082 0.024 DBMET01958 | DBMET01958 | |
| 0.053 | 0.227 | 0.29 | Thrombolytic | 0.145 0.086 DBMET01958 0.196 0.054 DBMET01959 0.203 0.05 DBMET01961 0.29 0.026 DBMET00680 0.271 0.029 DBMET01956 | DBMET00680 | |
| 0.016 | 0.193 | 0.039 | MAP3K5 inhibitor | 0.039 0.027 DBMET01958 | DBMET01958 | |
| 0.045 | 0.225 | 0.104 | Potassium channel (Voltage-sensitive) activator | 0.104 0.048 DBMET01958 | DBMET01958 | |
| 0.013 | 0.196 | 0.058 | CDK5/p25 inhibitor | 0.058 0.016 DBMET01958 | DBMET01958 | |
| 0.018 | 0.202 | 0.062 | Cyclin A2 inhibitor | 0.062 0.045 DBMET01958 | DBMET01958 | |
| 0.011 | 0.197 | 0.092 | Cyclin E inhibitor | 0.092 0.027 DBMET01958 | DBMET01958 | |
| 0.007 | 0.195 | 0.022 | Alpha 2d adrenoreceptor agonist | 0.022 0.015 DBMET01958 | DBMET01958 | |
| 0.037 | 0.227 | 0.065 | Lipocortins synthesis agonist | 0.065 0.027 DBMET00680 0.063 0.031 DBMET01956 | DBMET00680 | |
| 0.027 | 0.218 | 0.074 | Dihydroorotate oxidase inhibitor | 0.074 0.014 DBMET01958 | DBMET01958 | |
| 0.048 | 0.241 | 0.144 | Cyclin-dependent kinase 7 inhibitor | 0.144 0.064 DBMET01958 | DBMET01958 | |
| 0.078 | 0.272 | 0.171 | Melanin inhibitor | 0.155 0.075 DBMET01958 0.171 0.058 DBMET00680 0.166 0.063 DBMET01956 | DBMET00680 | |
| 0.038 | 0.233 | 0.12 | ATPase (Vacuolar H+) inhibitor | 0.081 0.077 DBMET01961 0.117 0.022 DBMET00680 0.12 0.02 DBMET01956 | DBMET01956 | |
| 0.029 | 0.227 | 0.142 | Potassium channel (Ca-activated) activator | 0.142 0.03 DBMET01958 | DBMET01958 | |
| 0.012 | 0.21 | 0.041 | Protein kinase (CK1) epsilon inhibitor | 0.041 0.024 DBMET01958 | DBMET01958 | |
| 0.006 | 0.203 | 0.035 | Poly(ADP-ribose) polymerase 2 inhibitor | 0.035 0.014 DBMET01958 | DBMET01958 | |
| 0.005 | 0.203 | 0.029 | Uridine phosphorylase inhibitor | 0.029 0.019 DBMET01958 | DBMET01958 | |
| 0.114 | 0.312 | 0.459 | Immunosuppressant | 0.267 0.136 DBMET01961 0.459 0.044 DBMET00680 0.442 0.049 DBMET01956 | DBMET00680 | |
| 0.059 | 0.258 | 0.229 | EphB2 antagonist | 0.229 0.069 DBMET01958 | DBMET01958 | |
| 0.016 | 0.218 | 0.055 | Cyclin A inhibitor | 0.055 0.048 DBMET01958 | DBMET01958 | |
| 0.042 | 0.246 | 0.097 | TRKA antagonist | 0.097 0.093 DBMET01958 | DBMET01958 | |
| 0.034 | 0.237 | 0.15 | Polo-like kinase-4 inhibitor | 0.15 0.036 DBMET01958 | DBMET01958 | |
| 0.055 | 0.261 | 0.085 | T cell inhibitor | 0.085 0.049 DBMET00680 0.078 0.075 DBMET01956 | DBMET00680 | |
| 0.017 | 0.224 | 0.067 | Antibiotic Aminoglycoside-like | 0.039 0.021 DBMET01961 0.067 0.007 DBMET00680 0.067 0.007 DBMET01956 | DBMET01956 | |
| 0.037 | 0.245 | 0.057 | Heme oxygenase stimulant | 0.057 0.055 DBMET00314 | DBMET00314 | |
| 0.037 | 0.245 | 0.101 | Cyclin-dependent kinase 9 inhibitor | 0.101 0.061 DBMET01958 | DBMET01958 | |
| 0.016 | 0.224 | 0.063 | Cyclin A1 inhibitor | 0.063 0.032 DBMET01958 0.055 0.05 DBMET01959 | DBMET01958 | |
| 0.018 | 0.226 | 0.037 | Potassium channel Kv1.1 blocker | 0.037 0.029 DBMET01958 | DBMET01958 | |
| 0.043 | 0.252 | 0.179 | AMP-activated protein kinase stimulant | 0.147 0.03 DBMET01958 0.177 0.015 DBMET00680 0.179 0.015 DBMET01956 | DBMET01956 | |
| 0.036 | 0.245 | 0.095 | Keratolytic | 0.095 0.033 DBMET01958 | DBMET01958 | |
| 0.027 | 0.236 | 0.047 | CD45 antagonist | 0.047 0.043 DBMET01958 | DBMET01958 | |
| 0.033 | 0.244 | 0.162 | Expectorant | 0.162 0.031 DBMET00680 0.161 0.031 DBMET01956 | DBMET00680 | |
| 0.01 | 0.221 | 0.056 | Somatostatin 1 antagonist | 0.056 0.017 DBMET01959 0.039 0.027 DBMET01961 | DBMET01959 | |
| 0.009 | 0.222 | 0.047 | Inosine monophosphate dehydrogenase inhibitor | 0.047 0.017 DBMET01958 | DBMET01958 | |
| 0.071 | 0.288 | 0.289 | Death-associated protein kinase 3 inhibitor | 0.289 0.041 DBMET01958 0.155 0.115 DBMET01961 | DBMET01958 | |
| 0.008 | 0.226 | 0.045 | Nicotinic acid receptor agonist | 0.045 0.017 DBMET01958 | DBMET01958 | |
| 0.054 | 0.273 | 0.166 | Protein kinase (CK1) gamma 1 inhibitor | 0.166 0.057 DBMET01958 | DBMET01958 | |
| 0.027 | 0.247 | 0.052 | Alpha 1b adrenoreceptor agonist | 0.05 0.036 DBMET00255 0.052 0.031 DBMET01958 | DBMET01958 | |
| 0.124 | 0.347 | 0.588 | Antibacterial | 0.217 0.21 DBMET01958 0.227 0.2 DBMET01959 0.346 0.104 DBMET01961 0.585 0.022 DBMET00680 0.588 0.021 DBMET01956 | DBMET01956 | |
| 0.006 | 0.229 | 0.049 | TRPM8 blocker | 0.049 0.016 DBMET01958 | DBMET01958 | |
| 0.013 | 0.236 | 0.064 | Somatostatin 5 agonist | 0.064 0.008 DBMET01959 0.045 0.015 DBMET01961 | DBMET01959 | |
| 0.009 | 0.232 | 0.048 | Fructose-1,6-bisphosphatase inhibitor | 0.048 0.027 DBMET01958 | DBMET01958 | |
| 0.08 | 0.304 | 0.18 | Prostaglandin dehydrogenase inhibitor | 0.18 0.172 DBMET01958 | DBMET01958 | |
| 0.066 | 0.289 | 0.249 | Interleukin antagonist | 0.202 0.083 DBMET01958 0.249 0.062 DBMET01959 0.153 0.116 DBMET01961 | DBMET01959 | |
| 0.022 | 0.257 | 0.074 | Heparanase inhibitor | 0.072 0.01 DBMET00680 0.074 0.009 DBMET01956 | DBMET01956 | |
| 0.041 | 0.281 | 0.096 | Proteasome inhibitor | 0.096 0.093 DBMET01958 | DBMET01958 | |
| 0.008 | 0.249 | 0.024 | Thyroid hormone agonist | 0.024 0.023 DBMET01958 | DBMET01958 | |
| 0.108 | 0.349 | 0.213 | Antiobesity | 0.213 0.194 DBMET00680 | DBMET00680 | |
| 0.014 | 0.257 | 0.079 | TRPA1 antagonist | 0.079 0.026 DBMET01958 | DBMET01958 | |
| 0.111 | 0.358 | 0.288 | Sodium/bile acid cotransporter inhibitor | 0.276 0.101 DBMET00254 0.288 0.09 DBMET00314 0.202 0.185 DBMET01961 0.218 0.164 DBMET00680 0.232 0.148 DBMET01956 | DBMET00314 | |
| 0.004 | 0.253 | 0.026 | Estrogen receptor beta agonist | 0.026 0.025 DBMET00254 | DBMET00254 | |
| 0.082 | 0.339 | 0.207 | Lipoxygenase inhibitor | 0.207 0.133 DBMET01958 0.175 0.169 DBMET00314 | DBMET01958 | |
| 0.052 | 0.314 | 0.129 | Interleukin 4 antagonist | 0.126 0.076 DBMET00254 0.119 0.087 DBMET00314 0.129 0.073 DBMET00680 0.124 0.08 DBMET01956 | DBMET00680 | |
| 0.009 | 0.272 | 0.038 | Bombesin 1 receptor antagonist | 0.038 0.024 DBMET01958 | DBMET01958 | |
| 0.045 | 0.308 | 0.293 | Pyruvate kinase inhibitor | 0.293 0.049 DBMET01958 | DBMET01958 | |
| 0.039 | 0.303 | 0.243 | Amylase inhibitor | 0.174 0.054 DBMET01958 0.107 0.09 DBMET01961 0.243 0.03 DBMET00680 0.235 0.033 DBMET01956 | DBMET00680 | |
| 0.093 | 0.358 | 0.206 | Cyclin-dependent kinase 3 inhibitor | 0.206 0.03 DBMET01958 | DBMET01958 | |
| 0.04 | 0.305 | 0.083 | Phosphodiesterase 7B inhibitor | 0.083 0.082 DBMET01958 | DBMET01958 | |
| 0.033 | 0.3 | 0.132 | Cyclin-dependent kinase inhibitor | 0.132 0.066 DBMET01958 | DBMET01958 | |
| 0.043 | 0.313 | 0.156 | Toll-Like receptor 4 antagonist | 0.099 0.071 DBMET01961 0.156 0.018 DBMET00680 0.146 0.023 DBMET01956 | DBMET00680 | |
| 0.083 | 0.356 | 0.394 | Alpha-glucosidase inhibitor | 0.214 0.21 DBMET01958 0.383 0.122 DBMET00680 0.394 0.118 DBMET01956 | DBMET01956 | |
| 0.029 | 0.305 | 0.093 | Bronchodilator | 0.093 0.072 DBMET00314 | DBMET00314 | |
| 0.037 | 0.313 | 0.104 | Thioredoxin inhibitor | 0.103 0.045 DBMET00680 0.104 0.044 DBMET01956 | DBMET01956 | |
| 0.02 | 0.298 | 0.154 | Cyclin B3 inhibitor | 0.154 0.013 DBMET01958 | DBMET01958 | |
| 0.05 | 0.328 | 0.137 | Protein kinase (CK1) gamma 3 inhibitor | 0.137 0.105 DBMET01958 | DBMET01958 | |
| 0.023 | 0.302 | 0.088 | Aryl hydrocarbon receptor antagonist | 0.088 0.02 DBMET01958 | DBMET01958 | |
| 0.019 | 0.299 | 0.037 | Glucose-6-phosphate dehydrogenase inhibitor | 0.037 0.028 DBMET01961 | DBMET01961 | |
| 0.024 | 0.304 | 0.103 | Cyclin-dependent kinase 2 inhibitor | 0.103 0.066 DBMET01958 | DBMET01958 | |
| 0.018 | 0.304 | 0.078 | Potassium channel (Inward rectifier) activator | 0.078 0.009 DBMET01958 | DBMET01958 | |
| 0.006 | 0.292 | 0.022 | Somatostatin 3 antagonist | 0.022 0.012 DBMET01958 | DBMET01958 | |
| 0.016 | 0.305 | 0.078 | Phosphodiesterase 5A inhibitor | 0.078 0.042 DBMET01958 | DBMET01958 | |
| 0.017 | 0.308 | 0.073 | Potassium channel (ATP-sensitive) activator | 0.073 0.009 DBMET01958 | DBMET01958 | |
| 0.014 | 0.307 | 0.088 | Protein 50S ribosomal subunit inhibitor | 0.088 0.017 DBMET00680 0.084 0.018 DBMET01956 | DBMET00680 | |
| 0.015 | 0.309 | 0.087 | Phosphodiesterase V inhibitor | 0.087 0.035 DBMET01958 | DBMET01958 | |
| 0.025 | 0.327 | 0.129 | Potassium channel activator | 0.129 0.028 DBMET01958 | DBMET01958 | |
| 0.02 | 0.323 | 0.094 | Bombesin 1 receptor agonist | 0.054 0.049 DBMET00255 0.094 0.02 DBMET01958 | DBMET01958 | |
| 0.011 | 0.314 | 0.052 | Dihydroorotase inhibitor | 0.052 0.022 DBMET01958 | DBMET01958 | |
| 0.027 | 0.33 | 0.089 | I kappa B kinase 1 inhibitor | 0.089 0.029 DBMET01958 | DBMET01958 | |
| 0.011 | 0.317 | 0.036 | Retinoic acid alpha receptor agonist | 0.036 0.033 DBMET01958 | DBMET01958 | |
| 0.062 | 0.369 | 0.526 | Antioxidant | 0.229 0.096 DBMET00254 0.208 0.108 DBMET00314 0.189 0.123 DBMET01961 0.526 0.017 DBMET00680 0.499 0.02 DBMET01956 | DBMET00680 | |
| 0.012 | 0.32 | 0.045 | Neuraminidase (Influenza A) inhibitor | 0.045 0.033 DBMET00680 | DBMET00680 | |
| 0.027 | 0.335 | 0.179 | Tubulin antagonist | 0.179 0.045 DBMET01958 | DBMET01958 | |
| 0.02 | 0.33 | 0.093 | ALK inhibitor | 0.093 0.046 DBMET01958 | DBMET01958 | |
| 0.073 | 0.387 | 0.13 | Papain-like protease (SARS coronavirus) inhibitor | 0.112 0.105 DBMET01958 0.13 0.06 DBMET00314 | DBMET00314 | |
| 0.025 | 0.345 | 0.119 | Somatostatin 1 agonist | 0.119 0.024 DBMET01959 0.102 0.033 DBMET01961 | DBMET01959 | |
| 0.019 | 0.34 | 0.082 | Pim-1 kinase inhibitor | 0.082 0.078 DBMET01958 | DBMET01958 | |
| 0.032 | 0.354 | 0.155 | Phosphodiesterase XI inhibitor | 0.155 0.009 DBMET01958 | DBMET01958 | |
| 0.032 | 0.354 | 0.155 | Phosphodiesterase 11A inhibitor | 0.155 0.009 DBMET01958 | DBMET01958 | |
| 0.014 | 0.339 | 0.1 | Cyclin-dependent kinase 1 inhibitor | 0.1 0.066 DBMET01958 | DBMET01958 | |
| 0.027 | 0.353 | 0.166 | Protein kinase (CK1) gamma inhibitor | 0.166 0.059 DBMET01958 | DBMET01958 | |
| 0.067 | 0.397 | 0.184 | 12-Lipoxygenase inhibitor | 0.184 0.169 DBMET01958 | DBMET01958 | |
| 0.029 | 0.36 | 0.111 | Alkaline phosphatase inhibitor | 0.111 0.099 DBMET01958 | DBMET01958 | |
| 0.032 | 0.367 | 0.213 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.213 0.067 DBMET01958 | DBMET01958 | |
| 0.049 | 0.384 | 0.48 | Free radical scavenger | 0.22 0.083 DBMET00254 0.21 0.09 DBMET00314 0.48 0.018 DBMET00680 0.461 0.02 DBMET01956 | DBMET00680 | |
| 0.018 | 0.356 | 0.072 | Sirtuin 1 inhibitor | 0.071 0.043 DBMET01958 0.072 0.043 DBMET01959 | DBMET01959 | |
| 0.018 | 0.362 | 0.133 | Protein kinase B gamma inhibitor | 0.133 0.021 DBMET01959 | DBMET01959 | |
| 0.013 | 0.361 | 0.124 | Check point kinase 2 inhibitor | 0.124 0.046 DBMET01958 | DBMET01958 | |
| 0.027 | 0.376 | 0.148 | Protein kinase (CK1) gamma 2 inhibitor | 0.148 0.049 DBMET01958 | DBMET01958 | |
| 0.054 | 0.405 | 0.364 | Hepatoprotectant | 0.167 0.092 DBMET01961 0.364 0.017 DBMET00680 0.353 0.019 DBMET01956 | DBMET00680 | |
| 0.036 | 0.389 | 0.137 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.137 0.107 DBMET01958 | DBMET01958 | |
| 0.029 | 0.391 | 0.242 | Dyrk kinase inhibitor | 0.242 0.076 DBMET01958 | DBMET01958 | |
| 0.011 | 0.375 | 0.097 | Monophenol monooxygenase inhibitor | 0.092 0.082 DBMET00680 0.097 0.078 DBMET01956 | DBMET01956 | |
| 0.019 | 0.387 | 0.156 | Glutamate receptor antagonist | 0.156 0.047 DBMET01958 | DBMET01958 | |
| 0.013 | 0.382 | 0.063 | Acid-sensing ion channel blocker | 0.063 0.008 DBMET01958 | DBMET01958 | |
| 0.004 | 0.374 | 0.042 | Somatostatin 5 antagonist | 0.042 0.017 DBMET01959 | DBMET01959 | |
| 0.024 | 0.394 | 0.163 | CDC-like kinase 1 inhibitor | 0.163 0.06 DBMET01958 | DBMET01958 | |
| 0.038 | 0.413 | 0.231 | Hypolipemic | 0.231 0.077 DBMET00680 0.194 0.099 DBMET01956 | DBMET00680 | |
| 0.07 | 0.448 | 0.355 | Death-associated protein kinase 2 inhibitor | 0.355 0.005 DBMET01958 0.197 0.036 DBMET01959 0.168 0.071 DBMET01961 | DBMET01958 | |
| 0.042 | 0.429 | 0.325 | Nitric oxide antagonist | 0.141 0.104 DBMET01961 0.325 0.036 DBMET00680 0.304 0.04 DBMET01956 | DBMET00680 | |
| 0.024 | 0.416 | 0.247 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.247 0.069 DBMET01958 | DBMET01958 | |
| 0.074 | 0.472 | 0.155 | Catenin beta inhibitor | 0.155 0.095 DBMET01958 | DBMET01958 | |
| 0.012 | 0.415 | 0.063 | CDK2/cyclin E2 inhibitor | 0.063 0.057 DBMET01958 | DBMET01958 | |
| 0.019 | 0.426 | 0.167 | CDC-like kinase 2 inhibitor | 0.167 0.084 DBMET01958 | DBMET01958 | |
| 0.005 | 0.412 | 0.061 | Phosphodiesterase 3B inhibitor | 0.061 0.019 DBMET01958 | DBMET01958 | |
| 0.056 | 0.467 | 0.238 | Angiogenesis inhibitor | 0.189 0.182 DBMET01958 0.213 0.155 DBMET00680 0.238 0.132 DBMET01956 | DBMET01956 | |
| 0.02 | 0.432 | 0.156 | Clk dual-specificity kinase inhibitor | 0.156 0.109 DBMET01958 | DBMET01958 | |
| 0.094 | 0.511 | 0.426 | Interleukin 2 agonist | 0.345 0.048 DBMET01959 0.224 0.151 DBMET00314 0.426 0.02 DBMET01961 0.378 0.034 DBMET00680 0.392 0.03 DBMET01956 | DBMET01961 | |
| 0.041 | 0.462 | 0.097 | Interleukin 12 antagonist | 0.097 0.058 DBMET00680 0.095 0.063 DBMET01956 | DBMET00680 | |
| 0.037 | 0.475 | 0.166 | Aurora-C kinase inhibitor | 0.166 0.035 DBMET01958 | DBMET01958 | |
| 0.029 | 0.472 | 0.095 | Interleukin 1b antagonist | 0.095 0.087 DBMET01958 | DBMET01958 | |
| 0.005 | 0.448 | 0.133 | Antineoplastic antibiotic | 0.133 0.035 DBMET00680 0.119 0.039 DBMET01956 | DBMET00680 | |
| 0.019 | 0.476 | 0.144 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.144 0.079 DBMET01958 | DBMET01958 | |
| 0.016 | 0.478 | 0.142 | CDC-like kinase 4 inhibitor | 0.142 0.108 DBMET01958 | DBMET01958 | |
| 0.008 | 0.472 | 0.231 | Cyclin-dependent kinase 5 inhibitor | 0.231 0.017 DBMET01958 | DBMET01958 | |
| 0.024 | 0.491 | 0.19 | Anticoagulant | 0.172 0.065 DBMET00680 0.19 0.057 DBMET01956 | DBMET01956 | |
| 0.028 | 0.522 | 0.115 | CDC-like kinase 3 inhibitor | 0.115 0.05 DBMET01958 | DBMET01958 | |
| 0.009 | 0.51 | 0.064 | Neuraminidase (influenza) inhibitor | 0.064 0.044 DBMET00680 0.062 0.048 DBMET01956 | DBMET00680 | |
| 0.026 | 0.536 | 0.1 | DNA polymerase I inhibitor | 0.098 0.088 DBMET01961 0.1 0.086 DBMET00680 0.095 0.092 DBMET01956 | DBMET00680 | |
| 0.077 | 0.589 | 0.134 | CC chemokine 6 receptor antagonist | 0.134 0.056 DBMET00680 0.127 0.081 DBMET01956 | DBMET00680 | |
| 0.029 | 0.545 | 0.235 | Hemostatic | 0.123 0.107 DBMET01961 0.151 0.066 DBMET00680 0.235 0.024 DBMET01956 | DBMET01956 | |
| 0.006 | 0.527 | 0.312 | Selectin antagonist | 0.31 0.005 DBMET00680 0.312 0.005 DBMET01956 | DBMET01956 | |
| 0.015 | 0.538 | 0.059 | Benzodiazepine inverse agonist | 0.059 0.015 DBMET01958 | DBMET01958 | |
| 0.007 | 0.549 | 0.075 | Cyclin B1 inhibitor | 0.075 0.026 DBMET01958 | DBMET01958 | |
| 0.013 | 0.555 | 0.07 | Glucose-6-phosphate translocase inhibitor | 0.07 0.016 DBMET00680 0.062 0.022 DBMET01956 | DBMET00680 | |
| 0.005 | 0.551 | 0.073 | Cyclin B2 inhibitor | 0.073 0.019 DBMET01958 | DBMET01958 | |
| 0.008 | 0.56 | 0.069 | Phosphodiesterase III inhibitor | 0.069 0.044 DBMET01958 | DBMET01958 | |
| 0.017 | 0.573 | 0.268 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.268 0.033 DBMET01958 | DBMET01958 | |
| 0.02 | 0.582 | 0.057 | Adenine nucleotide translocase inhibitor | 0.057 0.036 DBMET00680 0.055 0.039 DBMET01956 | DBMET00680 | |
| 0.005 | 0.582 | 0.069 | Cyclin B inhibitor | 0.069 0.022 DBMET01958 | DBMET01958 | |
| 0.017 | 0.609 | 0.553 | Angiogenesis stimulant | 0.158 0.117 DBMET01961 0.553 0.009 DBMET00680 0.553 0.009 DBMET01956 | DBMET01956 | |
| 0.005 | 0.623 | 0.043 | Mineralocorticoid receptor antagonist | 0.043 0.042 DBMET01958 | DBMET01958 | |
| 0.011 | 0.654 | 0.08 | Aminoacyl-tRNA synthetase inhibitor | 0.08 0.078 DBMET01959 | DBMET01959 | |
| 0.045 | 0.703 | 0.652 | Antiinflammatory | 0.368 0.16 DBMET01961 0.652 0.04 DBMET00680 0.635 0.044 DBMET01956 | DBMET00680 | |
| 0.047 | 0.719 | 0.192 | Death-associated protein kinase 1 inhibitor | 0.192 0.009 DBMET01958 | DBMET01958 | |
| 0.029 | 0.713 | 0.53 | Hypoglycemic | 0.53 0.013 DBMET00680 0.498 0.015 DBMET01956 | DBMET00680 | |
| 0.023 | 0.775 | 0.646 | Cyclophilin D inhibitor | 0.646 0.02 DBMET00680 0.635 0.022 DBMET01956 | DBMET00680 | |
| 0.019 | 0.871 | 0.11 | Transcription factor NF kappa B stimulant | 0.103 0.036 DBMET00680 0.11 0.031 DBMET01956 | DBMET01956 | |
| 0.011 | 0.87 | 0.281 | Platelet adhesion inhibitor | 0.28 0.04 DBMET00680 0.281 0.04 DBMET01956 | DBMET01956 | |
| 0.009 | 0.913 | 0.047 | Factor IXa inhibitor | 0.047 0.043 DBMET00680 | DBMET00680 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |